CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | chlorinated steroid |
|
Accession: | CHEBI:77175
|
browse the term
|
Definition: | A steroid which is substituted with one or more chlorine atoms in any position. |
Synonyms: | related_synonym: | chlorinated steroids |
|
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression |
ISO |
alclometasone dipropionate results in decreased expression of CCL2 protein |
CTD |
PMID:20116850 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
increases expression |
ISO |
alclometasone dipropionate results in increased expression of CCL3 protein |
CTD |
PMID:20116850 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
increases expression |
ISO |
alclometasone dipropionate results in increased expression of CCL4 protein |
CTD |
PMID:20116850 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Csf2 |
colony stimulating factor 2 |
decreases expression |
ISO |
alclometasone dipropionate results in decreased expression of CSF2 protein |
CTD |
PMID:11407316 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Ifng |
interferon gamma |
decreases expression |
ISO |
alclometasone dipropionate results in decreased expression of IFNG protein |
CTD |
PMID:11407316 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il2 |
interleukin 2 |
decreases expression |
ISO |
alclometasone dipropionate results in decreased expression of IL2 protein |
CTD |
PMID:11407316 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il3 |
interleukin 3 |
decreases expression |
ISO |
alclometasone dipropionate results in decreased expression of IL3 protein |
CTD |
PMID:11407316 |
|
NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066
|
|
G |
Il4 |
interleukin 4 |
decreases expression |
ISO |
alclometasone dipropionate results in decreased expression of IL4 protein |
CTD |
PMID:11407316 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il5 |
interleukin 5 |
decreases expression |
ISO |
alclometasone dipropionate results in decreased expression of IL5 protein |
CTD |
PMID:11407316 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression |
ISO |
alclometasone dipropionate results in decreased expression of VEGFA protein |
CTD |
PMID:20116850 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions increases expression increases secretion |
ISO |
Beclomethasone inhibits the reaction [ABCB1 protein results in decreased susceptibility to Doxorubicin]; Beclomethasone inhibits the reaction [ABCB1 protein results in increased export of fluorexon]; Elacridar inhibits the reaction [ABCB1 protein results in increased secretion of Beclomethasone]; valspodar inhibits the reaction [ABCB1 protein results in increased secretion of Beclomethasone] Beclomethasone results in increased expression of ABCB1 mRNA; Beclomethasone results in increased expression of ABCB1 protein |
CTD |
PMID:15370884 PMID:16442095 PMID:22464980 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
increases expression |
ISO |
Beclomethasone results in increased expression of ABCB4 mRNA |
CTD |
PMID:15370884 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
increases expression |
ISO |
Beclomethasone results in increased expression of ABCC1 mRNA |
CTD |
PMID:15370884 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
multiple interactions increases activity |
ISO |
Beclomethasone inhibits the reaction [ABCG2 protein affects the transport of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine]; Beclomethasone inhibits the reaction [ABCG2 protein results in increased export of Mitoxantrone] Beclomethasone results in increased activity of ABCG2 protein |
CTD |
PMID:15365089 PMID:16442095 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Acp5 |
acid phosphatase 5, tartrate resistant |
decreases activity |
ISO |
Beclomethasone results in decreased activity of ACP5 protein |
CTD |
PMID:8429434 |
|
NCBI chr 8:20,663,984...20,670,604
Ensembl chr 8:20,663,985...20,667,929
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
increases expression |
ISO |
Beclomethasone results in increased expression of ADRB2 mRNA |
CTD |
PMID:9032216 PMID:15679717 |
|
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
|
|
G |
Bdkrb1 |
bradykinin receptor B1 |
decreases expression |
ISO |
Beclomethasone results in decreased expression of BDKRB1 mRNA |
CTD |
PMID:18039523 |
|
NCBI chr 6:124,510,827...124,514,475
Ensembl chr 6:124,510,870...124,513,747
|
|
G |
Bglap |
bone gamma-carboxyglutamate protein |
decreases expression |
ISO |
Beclomethasone results in decreased expression of BGLAP protein |
CTD |
PMID:7746775 PMID:9232087 PMID:9544892 |
|
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
|
|
G |
Casp9 |
caspase 9 |
increases activity |
ISO |
Beclomethasone results in increased activity of CASP9 protein |
CTD |
PMID:11734450 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
increases expression |
ISO |
Beclomethasone results in increased expression of CAT protein |
CTD |
PMID:10445599 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
multiple interactions |
ISO |
Beclomethasone inhibits the reaction [IL13 protein results in increased expression of CCL11 protein] |
CTD |
PMID:17988555 |
|
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression |
ISO |
Beclomethasone results in decreased expression of CCL2 protein |
CTD |
PMID:20116850 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
increases expression |
ISO |
Beclomethasone results in increased expression of CCL3 protein |
CTD |
PMID:20116850 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
increases expression |
ISO |
Beclomethasone results in increased expression of CCL4 protein |
CTD |
PMID:20116850 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions decreases expression |
ISO |
[Beclomethasone co-treated with Albuterol] results in decreased secretion of CCL5 protein; [Beclomethasone co-treated with Formoterol Fumarate] results in decreased secretion of CCL5 protein; Beclomethasone inhibits the reaction [TNF protein results in increased secretion of CCL5 protein] Beclomethasone results in decreased expression of CCL5 mRNA; Beclomethasone results in decreased expression of CCL5 protein |
CTD |
PMID:8534483 PMID:10903220 PMID:14643170 PMID:15679717 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Cd44 |
CD44 molecule |
multiple interactions |
ISO |
Albuterol promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of CD44 protein]]; Albuterol promotes the reaction [Beclomethasone inhibits the reaction [IL4 protein results in decreased expression of CD44 protein]]; Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of CD44 protein]; Beclomethasone inhibits the reaction [IL4 protein results in decreased expression of CD44 protein]; Formoterol Fumarate promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of CD44 protein]]; Formoterol Fumarate promotes the reaction [Beclomethasone inhibits the reaction [IL4 protein results in decreased expression of CD44 protein]] |
CTD |
PMID:18076728 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Csf2 |
colony stimulating factor 2 |
multiple interactions decreases secretion increases activity |
ISO |
[Beclomethasone co-treated with Albuterol] results in decreased secretion of CSF2 protein; [Beclomethasone co-treated with Formoterol Fumarate] results in decreased secretion of CSF2 protein; Beclomethasone inhibits the reaction [Antigens, Dermatophagoides results in increased expression of CSF2 mRNA]; Beclomethasone inhibits the reaction [Antigens, Dermatophagoides results in increased secretion of CSF2 protein]; Beclomethasone inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein] Beclomethasone results in decreased secretion of CSF2 protein Beclomethasone results in increased activity of CSF2 protein |
CTD |
PMID:7545059 PMID:10460758 PMID:10868704 PMID:11167953 PMID:11730731 PMID:15679717 More...
|
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
decreases secretion |
ISO |
Beclomethasone results in decreased secretion of CXCL10 protein |
CTD |
PMID:17996064 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cyp2s1 |
cytochrome P450, family 2, subfamily s, polypeptide 1 |
decreases expression |
ISO |
Beclomethasone results in decreased expression of CYP2S1 mRNA |
CTD |
PMID:22155357 |
|
NCBI chr 1:81,309,948...81,325,303
Ensembl chr 1:81,310,451...81,325,303
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
multiple interactions increases expression |
ISO |
1-aminobenzotriazole inhibits the reaction [Beclomethasone results in increased expression of CYP3A5 mRNA]; Ketoconazole inhibits the reaction [Beclomethasone results in increased expression of CYP3A5 mRNA]; Mifepristone inhibits the reaction [Beclomethasone results in increased expression of CYP3A5 mRNA]; Paraoxon inhibits the reaction [Beclomethasone results in increased expression of CYP3A5 mRNA]; Physostigmine inhibits the reaction [Beclomethasone results in increased expression of CYP3A5 mRNA] |
CTD |
PMID:12538830 PMID:23512537 PMID:24555085 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Epx |
eosinophil peroxidase |
multiple interactions |
EXP |
Beclomethasone inhibits the reaction [sephadex results in increased expression of EPX protein] |
CTD |
PMID:10850854 |
|
NCBI chr10:72,666,865...72,677,952
Ensembl chr10:72,666,865...72,677,952
|
|
G |
Fcer1g |
Fc epsilon receptor Ig |
decreases expression |
EXP |
Beclomethasone results in decreased expression of FCER1G protein |
CTD |
PMID:1834581 |
|
NCBI chr13:83,649,447...83,654,248
Ensembl chr13:83,649,449...83,671,443
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
multiple interactions decreases activity |
ISO |
[Beclomethasone co-treated with Albuterol] inhibits the reaction [FGF2 protein results in increased secretion of FN1 protein]; [Beclomethasone co-treated with Formoterol Fumarate] inhibits the reaction [FGF2 protein results in increased secretion of FN1 protein]; Albuterol promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of CD44 protein]]; Albuterol promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of THY1 protein]]; Albuterol promotes the reaction [Beclomethasone results in decreased activity of FGF2 protein]; Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of CD44 protein]; Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of THY1 protein]; Formoterol Fumarate promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of CD44 protein]]; Formoterol Fumarate promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of THY1 protein]]; Formoterol Fumarate promotes the reaction [Beclomethasone results in decreased activity of FGF2 protein] |
CTD |
PMID:18076728 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
ISO |
[Beclomethasone co-treated with Albuterol] inhibits the reaction [FGF2 protein results in increased secretion of FN1 protein]; [Beclomethasone co-treated with Formoterol Fumarate] inhibits the reaction [FGF2 protein results in increased secretion of FN1 protein] |
CTD |
PMID:18076728 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
decreases expression |
ISO |
Beclomethasone results in decreased expression of FOS protein |
CTD |
PMID:9797757 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Ggt5 |
gamma-glutamyltransferase 5 |
increases activity increases expression multiple interactions |
ISO |
Beclomethasone results in increased activity of GGT5 protein Beclomethasone results in increased expression of GGT5 mRNA [Beclomethasone results in increased activity of GGT5 protein] which results in increased metabolism of Leukotriene C4 |
CTD |
PMID:11447392 |
|
NCBI chr20:13,043,255...13,071,523
Ensembl chr20:13,043,257...13,071,450
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
increases metabolic processing |
ISO |
HSD11B2 protein results in increased metabolism of Beclomethasone |
CTD |
PMID:16549198 |
|
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
Beclomethasone inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] |
CTD |
PMID:9150321 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Il10 |
interleukin 10 |
decreases secretion |
ISO |
Beclomethasone results in decreased secretion of IL10 protein |
CTD |
PMID:9819297 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il13 |
interleukin 13 |
multiple interactions increases activity |
ISO |
Beclomethasone inhibits the reaction [IL13 protein results in increased expression of CCL11 protein]; Beclomethasone inhibits the reaction [IL13 protein results in increased expression of IL6 mRNA]; Beclomethasone inhibits the reaction [IL13 protein results in increased expression of IL6 protein] Beclomethasone results in increased activity of IL13 protein |
CTD |
PMID:17988555 |
|
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions decreases secretion decreases expression |
ISO |
Beclomethasone inhibits the reaction [IL1B protein results in increased expression of SELE mRNA]; Beclomethasone inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]; Beclomethasone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein] Beclomethasone results in decreased secretion of IL1B protein Beclomethasone results in decreased expression of IL1B protein |
CTD |
PMID:7545059 PMID:9176529 PMID:9371735 PMID:10460758 PMID:15337628 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
decreases expression |
ISO |
Beclomethasone results in decreased expression of IL1RN protein |
CTD |
PMID:11015126 |
|
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
decreases expression |
ISO |
Beclomethasone results in decreased expression of IL2RA protein |
CTD |
PMID:8111605 PMID:9314351 |
|
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
|
|
G |
Il3 |
interleukin 3 |
multiple interactions |
ISO |
Beclomethasone inhibits the reaction [Antigens, Dermatophagoides results in increased expression of IL3 mRNA]; Beclomethasone inhibits the reaction [Antigens, Dermatophagoides results in increased secretion of IL3 protein] |
CTD |
PMID:11167953 |
|
NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066
|
|
G |
Il4 |
interleukin 4 |
multiple interactions decreases expression |
ISO |
Albuterol promotes the reaction [Beclomethasone inhibits the reaction [IL4 protein results in decreased expression of CD44 protein]]; Beclomethasone inhibits the reaction [IL4 protein results in decreased expression of CD44 protein]; Formoterol Fumarate promotes the reaction [Beclomethasone inhibits the reaction [IL4 protein results in decreased expression of CD44 protein]] Beclomethasone results in decreased expression of IL4 protein |
CTD |
PMID:7988651 PMID:18076728 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il5 |
interleukin 5 |
multiple interactions decreases expression |
ISO |
Beclomethasone inhibits the reaction [Antigens, Dermatophagoides results in increased expression of IL5 mRNA]; Beclomethasone inhibits the reaction [Antigens, Dermatophagoides results in increased secretion of IL5 protein] Beclomethasone results in decreased expression of IL5 protein |
CTD |
PMID:7988651 PMID:10813552 PMID:11167953 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
Beclomethasone inhibits the reaction [IL13 protein results in increased expression of IL6 mRNA]; Beclomethasone inhibits the reaction [IL13 protein results in increased expression of IL6 protein] |
CTD |
PMID:17988555 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Klk1c10 |
kallikrein 1-related peptidase C10 |
increases expression |
ISO |
Beclomethasone results in increased expression of KLK3 mRNA |
CTD |
PMID:9815800 |
|
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
|
|
G |
Ltf |
lactotransferrin |
multiple interactions decreases secretion |
ISO |
Beclomethasone inhibits the reaction [methylcholine results in increased secretion of LTF protein] Beclomethasone results in decreased secretion of LTF protein |
CTD |
PMID:11112886 |
|
NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:110,999,948...111,022,795
|
|
G |
Mefv |
MEFV innate immunity regulator, pyrin |
increases response to substance |
ISO |
MEFV mutant form results in increased susceptibility to Beclomethasone |
CTD |
PMID:20828792 |
|
NCBI chr10:11,786,948...11,796,977
Ensembl chr10:11,787,422...11,796,973
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
ISO |
Beclomethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP2 protein] |
CTD |
PMID:10455257 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
ISO |
Beclomethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] Beclomethasone results in decreased expression of MMP9 protein |
CTD |
PMID:10452757 PMID:10455257 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Nos2 |
nitric oxide synthase 2 |
decreases expression |
ISO |
Beclomethasone results in decreased expression of NOS2 protein |
CTD |
PMID:12668791 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity |
ISO |
Beclomethasone results in increased activity of NR1I2 protein |
CTD |
PMID:21068194 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
affects localization increases expression affects binding multiple interactions increases activity |
ISO EXP |
Beclomethasone affects the localization of NR3C1 protein Beclomethasone results in increased expression of NR3C1 mRNA Beclomethasone binds to NR3C1 protein [Beclomethasone co-treated with Albuterol] affects the localization of NR3C1 protein; [Beclomethasone co-treated with Formoterol Fumarate] affects the localization of NR3C1 protein; Beclomethasone affects the localization of and results in increased activity of NR3C1 protein; Beclomethasone binds to and results in increased activity of NR3C1 protein Beclomethasone results in increased activity of NR3C1 protein |
CTD |
PMID:16814 PMID:2207292 PMID:15362971 PMID:15679717 PMID:15860753 PMID:15862954 PMID:16507850 PMID:21543282 PMID:24555085 More...
|
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
increases activity |
ISO |
Beclomethasone results in increased activity of NR3C2 protein |
CTD |
PMID:15362971 |
|
NCBI chr19:30,715,634...31,059,885
Ensembl chr19:30,715,648...31,059,885
|
|
G |
Pla1a |
phospholipase A1 member A |
multiple interactions |
ISO |
Beclomethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PLA1A mRNA] |
CTD |
PMID:20573295 |
|
NCBI chr11:62,320,112...62,357,779
Ensembl chr11:62,320,493...62,357,779
|
|
G |
Pla2g4a |
phospholipase A2 group 4A |
decreases activity multiple interactions |
ISO |
Beclomethasone results in decreased activity of PLA2G4A protein Beclomethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PLA2G4A mRNA] |
CTD |
PMID:15337628 PMID:20573295 |
|
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
|
|
G |
Ppp1r14a |
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
multiple interactions |
EXP |
Beclomethasone inhibits the reaction [Acetylcholine results in increased phosphorylation of PPP1R14A protein] |
CTD |
PMID:18577381 |
|
NCBI chr 1:84,583,127...84,590,743
Ensembl chr 1:84,586,627...84,590,671
|
|
G |
Rhoa |
ras homolog family member A |
multiple interactions |
EXP |
Beclomethasone inhibits the reaction [[[Antigens, Bacterial co-treated with Allergens] results in increased expression of and results in increased activity of RHOA protein] which results in increased susceptibility to Acetylcholine]; Beclomethasone inhibits the reaction [[Antigens, Bacterial co-treated with Allergens] results in increased expression of and results in increased activity of RHOA protein]; Beclomethasone inhibits the reaction [[Antigens, Bacterial co-treated with Allergens] results in increased expression of RHOA mRNA] |
CTD |
PMID:18391481 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Rnase2 |
ribonuclease A family member 2 |
decreases expression |
ISO |
Beclomethasone results in decreased expression of RNASE2 protein |
CTD |
PMID:12166584 |
|
NCBI chr15:24,449,618...24,450,427
Ensembl chr15:24,449,611...24,450,479
|
|
G |
Rnase3 |
ribonuclease A family member 3 |
multiple interactions decreases expression |
ISO |
[Salmeterol Xinafoate co-treated with Beclomethasone] affects the reaction [Allergens results in increased expression of RNASE3 protein]; Beclomethasone affects the reaction [Allergens results in increased expression of RNASE3 protein] Beclomethasone results in decreased expression of RNASE3 protein |
CTD |
PMID:1443864 PMID:10513351 PMID:10573242 PMID:12166584 PMID:12587966 PMID:15144908 More...
|
|
NCBI chr15:24,511,894...24,512,764
Ensembl chr15:24,511,891...24,512,790
|
|
G |
Sele |
selectin E |
multiple interactions |
ISO |
Beclomethasone inhibits the reaction [IL1B protein results in increased expression of SELE mRNA] |
CTD |
PMID:9371735 |
|
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
Beclomethasone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Thy1 |
Thy-1 cell surface antigen |
multiple interactions |
ISO |
Albuterol promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of THY1 protein]]; Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of THY1 protein]; Formoterol Fumarate promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of THY1 protein]] |
CTD |
PMID:18076728 |
|
NCBI chr 8:44,389,495...44,394,688
Ensembl chr 8:44,389,513...44,394,659
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
increases expression |
ISO |
Beclomethasone results in increased expression of TIMP1 protein |
CTD |
PMID:10452757 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions decreases secretion |
ISO |
Beclomethasone inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Beclomethasone inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; Beclomethasone inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]; Beclomethasone inhibits the reaction [TNF protein results in increased secretion of CCL5 protein]; Beclomethasone inhibits the reaction [TNF protein results in increased secretion of CXCL8 protein] Beclomethasone results in decreased secretion of TNF protein |
CTD |
PMID:8937731 PMID:9150321 PMID:9819297 PMID:10100995 PMID:10903220 PMID:14643170 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
multiple interactions |
ISO |
Beclomethasone inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] |
CTD |
PMID:10100995 |
|
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression |
ISO |
Beclomethasone results in decreased expression of VEGFA protein |
CTD |
PMID:20116850 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Aacs |
acetoacetyl-CoA synthetase |
increases expression |
ISO |
Clobetasol results in increased expression of AACS mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:31,113,098...31,156,411
Ensembl chr12:31,113,098...31,160,954
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
increases expression |
ISO |
Clobetasol results in increased expression of ABCA1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abca2 |
ATP binding cassette subfamily A member 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ABCA2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:8,244,515...8,264,545
Ensembl chr 3:8,244,639...8,264,537
|
|
G |
Abcb6 |
ATP binding cassette subfamily B member 6 |
increases expression |
ISO |
Clobetasol results in increased expression of ABCB6 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:76,668,554...76,677,263
Ensembl chr 9:76,668,554...76,676,924
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ABCC1 mRNA |
CTD |
PMID:16882163 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcf1 |
ATP binding cassette subfamily F member 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ABCF1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr20:2,802,519...2,815,433
Ensembl chr20:2,802,488...2,815,433
|
|
G |
Acaa1a |
acetyl-CoA acyltransferase 1A |
increases expression |
ISO |
Clobetasol results in increased expression of ACAA1A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:119,079,401...119,088,626
Ensembl chr 8:119,079,775...119,088,624
|
|
G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
increases expression |
ISO |
Clobetasol results in increased expression of ACAA2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr18:68,345,136...68,373,246
Ensembl chr18:68,345,012...68,373,249
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
increases expression |
ISO |
Clobetasol results in increased expression of ACACA mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Acot11 |
acyl-CoA thioesterase 11 |
increases expression |
ISO |
Clobetasol results in increased expression of ACOT11 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:121,523,833...121,581,699
Ensembl chr 5:121,527,435...121,581,538
|
|
G |
Acsbg1 |
acyl-CoA synthetase bubblegum family member 1 |
increases expression |
ISO |
Clobetasol results in increased expression of ACSBG1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:54,991,294...55,047,276
Ensembl chr 8:54,991,296...55,047,391
|
|
G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
increases expression |
ISO |
Clobetasol results in increased expression of ACSS2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
increases expression |
ISO |
Clobetasol results in increased expression of ACTA2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Actb |
actin, beta |
increases expression |
ISO |
Clobetasol results in increased expression of ACTB mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Actg1 |
actin, gamma 1 |
increases expression |
ISO |
Clobetasol results in increased expression of ACTG1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232 Ensembl chr 3:105,619,737...105,624,232
|
|
G |
Actr1b |
actin related protein 1B |
increases expression |
ISO |
Clobetasol results in increased expression of ACTR1B mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:38,928,819...38,938,483
Ensembl chr 9:38,929,912...38,938,507
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
increases expression |
ISO |
Clobetasol results in increased expression of ADAMTS1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
|
|
G |
Adprh |
ADP-ribosylarginine hydrolase |
increases expression |
ISO |
Clobetasol results in increased expression of ADPRH mRNA |
CTD |
PMID:27462272 |
|
NCBI chr11:62,299,831...62,306,170
Ensembl chr11:62,299,793...62,306,931
|
|
G |
Agpat1 |
1-acylglycerol-3-phosphate O-acyltransferase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of AGPAT1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr20:4,135,955...4,144,880
Ensembl chr20:4,135,957...4,145,278
|
|
G |
Ahcyl1 |
adenosylhomocysteinase-like 1 |
increases expression |
ISO |
Clobetasol results in increased expression of AHCYL1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:195,294,149...195,328,586
Ensembl chr 2:195,294,153...195,345,815
|
|
G |
Ahnak |
AHNAK nucleoprotein |
decreases expression |
ISO |
Clobetasol results in decreased expression of AHNAK mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:205,882,225...205,970,934
Ensembl chr 1:205,882,273...205,970,926
|
|
G |
Ak3 |
adenylate kinase 3 |
increases expression |
ISO |
Clobetasol results in increased expression of AK3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:226,737,472...226,764,647
Ensembl chr 1:226,739,318...226,764,625
|
|
G |
Ak5 |
adenylate kinase 5 |
decreases expression |
ISO |
Clobetasol results in decreased expression of AK5 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:241,397,297...241,581,483
Ensembl chr 2:241,397,297...241,581,458
|
|
G |
Akap13 |
A-kinase anchoring protein 13 |
decreases expression |
ISO |
Clobetasol results in decreased expression of AKAP13 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:129,313,183...129,619,647
Ensembl chr 1:129,314,402...129,619,646
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B1 |
increases expression |
ISO |
Clobetasol results in increased expression of AKR1B1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
|
|
G |
Alcam |
activated leukocyte cell adhesion molecule |
decreases expression |
ISO |
Clobetasol results in decreased expression of ALCAM mRNA |
CTD |
PMID:27462272 |
|
NCBI chr11:48,336,123...48,536,296
Ensembl chr11:48,336,169...48,537,954
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
increases expression |
ISO |
Clobetasol results in increased expression of ALDH1A1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh1l2 |
aldehyde dehydrogenase 1 family, member L2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ALDH1L2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:20,254,246...20,305,793
Ensembl chr 7:20,254,233...20,305,776
|
|
G |
Alms1 |
ALMS1, centrosome and basal body associated protein |
decreases expression |
ISO |
Clobetasol results in decreased expression of ALMS1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:118,125,581...118,226,005
Ensembl chr 4:118,125,607...118,226,005
|
|
G |
Amfr |
autocrine motility factor receptor |
increases expression |
ISO |
Clobetasol results in increased expression of AMFR mRNA |
CTD |
PMID:27462272 |
|
NCBI chr19:10,996,705...11,032,260
Ensembl chr19:10,996,099...11,032,247
|
|
G |
Ankhd1 |
ankyrin repeat and KH domain containing 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ANKHD1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr18:28,161,882...28,260,917
Ensembl chr18:28,162,311...28,268,024
|
|
G |
Ankrd11 |
ankyrin repeat domain containing 11 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ANKRD11 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr19:50,940,284...51,098,962
Ensembl chr19:50,940,299...51,098,962
|
|
G |
Ankrd12 |
ankyrin repeat domain 12 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ANKRD12 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:105,583,273...105,687,957
Ensembl chr 9:105,584,065...105,687,911
|
|
G |
Ankrd46 |
ankyrin repeat domain 46 |
increases expression |
ISO |
Clobetasol results in increased expression of ANKRD46 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:67,647,202...67,668,180
Ensembl chr 7:67,647,204...67,668,132
|
|
G |
Ankrd52 |
ankyrin repeat domain 52 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ANKRD52 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:806,829...820,481
Ensembl chr 7:806,767...820,481
|
|
G |
Aox1 |
aldehyde oxidase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of AOX1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770
|
|
G |
Ap1m1 |
adaptor related protein complex 1 subunit mu 1 |
increases expression |
ISO |
Clobetasol results in increased expression of AP1M1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr16:17,586,886...17,602,410
Ensembl chr16:17,584,730...17,602,403
|
|
G |
Ap3d1 |
adaptor related protein complex 3 subunit delta 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of AP3D1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:8,970,249...9,005,651
Ensembl chr 7:8,970,291...9,005,643
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
decreases expression |
ISO |
Clobetasol results in decreased expression of APC mRNA |
CTD |
PMID:27462272 |
|
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
|
|
G |
Apc2 |
APC regulator of WNT signaling pathway 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of APC2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:9,392,336...9,414,364
Ensembl chr 7:9,392,336...9,414,310
|
|
G |
Apcdd1 |
APC down-regulated 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of APCDD1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr18:56,385,398...56,416,065
Ensembl chr18:56,385,264...56,416,070
|
|
G |
Apln |
apelin |
decreases expression |
ISO |
Clobetasol results in decreased expression of APLN mRNA |
CTD |
PMID:27462272 |
|
NCBI chr X:127,180,801...127,213,567
Ensembl chr X:127,203,823...127,213,391
|
|
G |
Arf3 |
ARF GTPase 3 |
increases expression |
ISO |
Clobetasol results in increased expression of ARF3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:129,886,082...129,912,022
Ensembl chr 7:129,886,082...129,912,002
|
|
G |
Arf4 |
ARF GTPase 4 |
increases expression |
ISO |
Clobetasol results in increased expression of ARF4 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr16:1,896,692...1,913,267
Ensembl chr16:1,896,546...1,913,261
|
|
G |
Arf5 |
ARF GTPase 5 |
increases expression |
ISO |
Clobetasol results in increased expression of ARF5 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:57,038,521...57,041,447
Ensembl chr 4:57,038,521...57,041,441
|
|
G |
Arfgef1 |
ARF guanine nucleotide exchange factor 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ARFGEF1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:8,982,061...9,076,326
Ensembl chr 5:8,981,540...9,076,326
|
|
G |
Arfgef2 |
ARF guanine nucleotide exchange factor 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ARFGEF2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:155,547,504...155,633,652
Ensembl chr 3:155,547,538...155,630,856
|
|
G |
Arhgap23 |
Rho GTPase activating protein 23 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ARHGAP23 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:82,437,578...82,496,846
Ensembl chr10:82,394,648...82,496,504
|
|
G |
Arhgap31 |
Rho GTPase activating protein 31 |
affects expression |
ISO |
Clobetasol affects the expression of ARHGAP31 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr11:62,038,635...62,151,564
Ensembl chr11:62,038,635...62,151,564
|
|
G |
Arhgap35 |
Rho GTPase activating protein 35 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ARHGAP35 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:77,202,436...77,319,298
Ensembl chr 1:77,202,436...77,319,298
|
|
G |
Arhgap5 |
Rho GTPase activating protein 5 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ARHGAP5 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 6:69,975,904...70,039,299
Ensembl chr 6:69,976,214...70,037,660
|
|
G |
Arhgef26 |
Rho guanine nucleotide exchange factor 26 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ARHGEF26 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:146,740,336...146,850,918
Ensembl chr 2:146,739,631...146,850,819
|
|
G |
Arhgef4 |
Rho guanine nucleotide exchange factor 4 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ARHGEF4 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:36,861,800...37,005,079
Ensembl chr 9:36,861,835...37,005,075
|
|
G |
Arid1b |
AT-rich interaction domain 1B |
decreases expression |
ISO |
Clobetasol results in decreased expression of ARID1B mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:45,567,991...45,923,644
Ensembl chr 1:45,563,623...45,923,493
|
|
G |
Arid2 |
AT-rich interaction domain 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ARID2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:127,447,192...127,565,987
Ensembl chr 7:127,447,278...127,563,512
|
|
G |
Arl1 |
ARF like GTPase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of ARL1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:23,120,004...23,131,173
Ensembl chr 7:23,119,589...23,131,898
|
|
G |
Arl2 |
ARF like GTPase 2 |
increases expression |
ISO |
Clobetasol results in increased expression of ARL2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:203,434,129...203,446,156
Ensembl chr 1:203,434,129...203,446,119
|
|
G |
Arl2bp |
ARF like GTPase 2 binding protein |
decreases expression |
ISO |
Clobetasol results in decreased expression of ARL2BP mRNA |
CTD |
PMID:27462272 |
|
NCBI chr19:10,336,921...10,346,555
Ensembl chr19:10,336,921...10,346,564
|
|
G |
Arl4a |
ARF like GTPase 4A |
decreases expression |
ISO |
Clobetasol results in decreased expression of ARL4A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 6:57,079,496...57,084,156
Ensembl chr 6:57,078,812...57,085,066
|
|
G |
Arl6ip1 |
ARL6 interacting reticulophagy regulator 1 |
increases expression |
ISO |
Clobetasol results in increased expression of ARL6IP1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:172,430,475...172,439,990
Ensembl chr 1:172,430,489...172,439,994
|
|
G |
Armcx4 |
armadillo repeat containing, X-linked 4 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ARMCX4 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr X:97,860,526...97,870,912
Ensembl chr X:97,860,629...97,870,912
|
|
G |
Ash1l |
ASH1 like histone lysine methyltransferase |
decreases expression |
ISO |
Clobetasol results in decreased expression of ASH1L mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:174,346,267...174,483,057
Ensembl chr 2:174,346,150...174,483,055
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
increases expression |
ISO |
Clobetasol results in increased expression of ASNS mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Asphd2 |
aspartate beta-hydroxylase domain containing 2 |
increases expression |
ISO |
Clobetasol results in increased expression of ASPHD2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:44,248,132...44,258,653
Ensembl chr12:44,248,145...44,257,772
|
|
G |
Asxl3 |
ASXL transcriptional regulator 3 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ASXL3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr18:13,593,529...13,766,324
Ensembl chr18:13,593,985...13,762,427
|
|
G |
Atg13 |
autophagy related 13 |
increases expression |
ISO |
Clobetasol results in increased expression of ATG13 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:77,647,069...77,681,028
Ensembl chr 3:77,645,790...77,681,043
|
|
G |
Atg4b |
autophagy related 4B, cysteine peptidase |
increases expression |
ISO |
Clobetasol results in increased expression of ATG4B mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:94,282,417...94,314,109
Ensembl chr 9:94,282,509...94,314,103
|
|
G |
Atox1 |
antioxidant 1 copper chaperone |
increases expression |
ISO |
Clobetasol results in increased expression of ATOX1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:39,564,855...39,579,892
Ensembl chr10:39,564,857...39,579,950
|
|
G |
Atp10b |
ATPase phospholipid transporting 10B |
decreases expression |
ISO |
Clobetasol results in decreased expression of ATP10B mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:27,495,207...27,751,313
Ensembl chr10:27,408,747...27,749,637
|
|
G |
Atp1a1 |
ATPase Na+/K+ transporting subunit alpha 1 |
increases expression |
ISO |
Clobetasol results in increased expression of ATP1A1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
|
|
G |
Atp1b2 |
ATPase Na+/K+ transporting subunit beta 2 |
increases expression |
ISO |
Clobetasol results in increased expression of ATP1B2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:54,318,698...54,324,933
Ensembl chr10:54,318,701...54,324,933
|
|
G |
Atp5f1a |
ATP synthase F1 subunit alpha |
increases expression |
ISO |
Clobetasol results in increased expression of ATP5F1A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794
|
|
G |
Atp5f1b |
ATP synthase F1 subunit beta |
increases expression |
ISO |
Clobetasol results in increased expression of ATP5F1B mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:515,454...521,858
Ensembl chr 7:515,460...567,273
|
|
G |
Atp5mc2 |
ATP synthase membrane subunit c locus 2 |
increases expression |
ISO |
Clobetasol results in increased expression of ATP5MC2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:133,791,341...133,799,713
Ensembl chr 7:133,791,342...133,799,733
|
|
G |
Atp5mf |
ATP synthase membrane subunit f |
increases expression |
ISO |
Clobetasol results in increased expression of ATP5MF mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:9,421,665...9,428,236
Ensembl chr12:9,421,579...9,428,236
|
|
G |
Atp5mj |
ATP synthase membrane subunit j |
increases expression |
ISO |
Clobetasol results in increased expression of ATP5MJ mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 6:131,018,737...131,024,488
Ensembl chr 1:168,472,329...168,472,610 Ensembl chr 1:168,472,329...168,472,610
|
|
G |
Atp5pd |
ATP synthase peripheral stalk subunit d |
increases expression |
ISO |
Clobetasol results in increased expression of ATP5PD mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:100,657,700...100,662,960
Ensembl chr10:100,657,708...100,663,479
|
|
G |
Atp5po |
ATP synthase peripheral stalk subunit OSCP |
increases expression |
ISO |
Clobetasol results in increased expression of ATP5PO mRNA |
CTD |
PMID:27462272 |
|
NCBI chr11:31,165,218...31,171,530
Ensembl chr11:31,165,217...31,171,592
|
|
G |
Atp6v0b |
ATPase H+ transporting V0 subunit B |
increases expression |
ISO |
Clobetasol results in increased expression of ATP6V0B mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:131,423,384...131,424,900
Ensembl chr 5:131,423,387...131,426,401
|
|
G |
Atp6v0c |
ATPase H+ transporting V0 subunit C |
increases expression |
ISO |
Clobetasol results in increased expression of ATP6V0C mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:13,196,204...13,202,580
Ensembl chr10:13,196,204...13,201,500
|
|
G |
Atp6v0e2 |
ATPase, H+ transporting V0 subunit e2 |
increases expression |
ISO |
Clobetasol results in increased expression of ATP6V0E2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:77,484,868...77,488,016
Ensembl chr 4:77,482,226...77,488,777
|
|
G |
Atrx |
ATRX, chromatin remodeler |
decreases expression |
ISO |
Clobetasol results in decreased expression of ATRX mRNA |
CTD |
PMID:27462272 |
|
NCBI chr X:70,850,981...70,997,330
Ensembl chr X:70,850,981...70,997,330
|
|
G |
Atxn2 |
ataxin 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ATXN2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:34,754,132...34,851,175
Ensembl chr12:34,754,137...34,851,479
|
|
G |
Atxn7l3b |
ataxin 7-like 3B |
increases expression |
ISO |
Clobetasol results in increased expression of ATXN7L3B mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:48,322,451...48,325,975
Ensembl chr 7:48,321,755...48,328,878
|
|
G |
Aurkb |
aurora kinase B |
increases expression |
ISO |
Clobetasol results in increased expression of AURKB mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
|
|
G |
B3gat1 |
beta-1,3-glucuronyltransferase 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of B3GAT1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:25,087,123...25,114,692
Ensembl chr 8:25,087,547...25,113,395
|
|
G |
B3gat2 |
beta-1,3-glucuronyltransferase 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of B3GAT2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:26,167,174...26,250,153
Ensembl chr 9:26,167,174...26,250,153
|
|
G |
Bach2 |
BTB domain and CNC homolog 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of BACH2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:46,632,338...46,982,676
Ensembl chr 5:46,638,317...46,977,877
|
|
G |
Basp1 |
brain abundant, membrane attached signal protein 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of BASP1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:75,816,130...75,863,801
Ensembl chr 2:75,816,122...75,864,043
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
Clobetasol results in increased expression of BAX mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bckdk |
branched chain ketoacid dehydrogenase kinase |
increases expression |
ISO |
Clobetasol results in increased expression of BCKDK mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:182,515,335...182,520,007
Ensembl chr 1:182,515,327...182,536,633
|
|
G |
Bcl6 |
BCL6, transcription repressor |
increases expression |
ISO |
Clobetasol results in increased expression of BCL6 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389
|
|
G |
Bcl7a |
BAF chromatin remodeling complex subunit BCL7A |
decreases expression |
ISO |
Clobetasol results in decreased expression of BCL7A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:33,211,978...33,243,903
Ensembl chr12:33,223,931...33,243,886
|
|
G |
Bcl9 |
BCL9, transcription coactivator |
decreases expression |
ISO |
Clobetasol results in decreased expression of BCL9 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:184,760,616...184,846,261
Ensembl chr 2:184,760,618...184,786,435
|
|
G |
Bcorl1 |
BCL6 co-repressor-like 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of BCORL1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr X:127,516,504...127,584,529
Ensembl chr X:127,537,538...127,584,087
|
|
G |
Bcr |
BCR activator of RhoGEF and GTPase |
decreases expression |
ISO |
Clobetasol results in decreased expression of BCR mRNA |
CTD |
PMID:27462272 |
|
NCBI chr20:13,469,325...13,596,942
Ensembl chr20:13,471,668...13,597,016
|
|
G |
Bdp1 |
BDP1 general transcription factor IIIB subunit |
decreases expression |
ISO |
Clobetasol results in decreased expression of BDP1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:31,378,407...31,470,140
Ensembl chr 2:31,378,924...31,470,119
|
|
G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
increases expression |
ISO |
Clobetasol results in increased expression of BHLHE40 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
|
|
G |
Birc6 |
baculoviral IAP repeat-containing 6 |
decreases expression |
ISO |
Clobetasol results in decreased expression of BIRC6 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 6:20,722,922...20,916,396
Ensembl chr 6:20,722,922...20,916,434
|
|
G |
Bltp3a |
bridge-like lipid transfer protein family member 3A |
decreases expression |
ISO |
Clobetasol results in decreased expression of BLTP3A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr20:5,910,261...5,954,641
Ensembl chr20:5,910,260...5,952,404
|
|
G |
Bmp7 |
bone morphogenetic protein 7 |
increases expression |
ISO |
Clobetasol results in increased expression of BMP7 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:161,639,915...161,716,938
Ensembl chr 3:161,516,462...161,716,788
|
|
G |
Bmpr2 |
bone morphogenetic protein receptor type 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of BMPR2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:61,192,718...61,307,280
Ensembl chr 9:61,190,566...61,301,809
|
|
G |
Bok |
BCL2 family apoptosis regulator BOK |
increases expression |
ISO |
Clobetasol results in increased expression of BOK mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:94,223,493...94,234,476
Ensembl chr 9:94,223,389...94,234,476
|
|
G |
Bop1 |
BOP1 ribosomal biogenesis factor |
increases expression |
ISO |
Clobetasol results in increased expression of BOP1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:108,172,062...108,195,875
Ensembl chr 7:108,172,066...108,195,931
|
|
G |
Bora |
bora, aurora kinase A activator |
decreases expression |
ISO |
Clobetasol results in decreased expression of BORA mRNA |
CTD |
PMID:27462272 |
|
NCBI chr15:75,797,624...75,835,599
Ensembl chr15:75,797,891...75,821,322
|
|
G |
Brd7 |
bromodomain containing 7 |
decreases expression |
ISO |
Clobetasol results in decreased expression of BRD7 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr19:18,708,792...18,737,497
Ensembl chr19:18,709,022...18,737,494
|
|
G |
Brk1 |
BRICK1 subunit of SCAR/WAVE actin nucleating complex |
increases expression |
ISO |
Clobetasol results in increased expression of BRK1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:146,750,821...146,766,050
Ensembl chr 4:146,750,821...146,768,856
|
|
G |
Brwd1 |
bromodomain and WD repeat domain containing 1 |
increases expression |
ISO |
Clobetasol results in increased expression of BRWD1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr11:35,286,364...35,378,768
Ensembl chr11:35,288,313...35,378,768
|
|
G |
Bsn |
bassoon (presynaptic cytomatrix protein) |
decreases expression |
ISO |
Clobetasol results in decreased expression of BSN mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:108,784,849...108,875,819
Ensembl chr 8:108,788,542...108,875,819
|
|
G |
Btbd2 |
BTB domain containing 2 |
increases expression |
ISO |
Clobetasol results in increased expression of BTBD2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:9,058,609...9,075,341
Ensembl chr 7:9,060,788...9,075,344
|
|
G |
Bub3 |
BUB3 mitotic checkpoint protein |
increases expression |
ISO |
Clobetasol results in increased expression of BUB3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:186,330,358...186,340,969
Ensembl chr 1:186,327,931...186,395,036
|
|
G |
C2 |
complement C2 |
increases expression |
ISO |
Clobetasol results in increased expression of C2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr20:3,951,474...3,970,376
Ensembl chr20:3,951,474...3,976,505
|
|
G |
Cabin1 |
calcineurin binding protein 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of CABIN1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr20:12,893,314...13,015,357
Ensembl chr20:12,893,358...13,015,357
|
|
G |
Calr |
calreticulin |
increases expression |
ISO |
Clobetasol results in increased expression of CALR mRNA |
CTD |
PMID:27462272 |
|
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
|
|
G |
Cand2 |
cullin-associated and neddylation-dissociated 2 (putative) |
decreases expression |
ISO |
Clobetasol results in decreased expression of CAND2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:148,835,050...148,864,039
Ensembl chr 4:148,835,053...148,863,153
|
|
G |
Capn10 |
calpain 10 |
increases expression |
ISO |
Clobetasol results in increased expression of CAPN10 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:93,498,132...93,510,494
Ensembl chr 9:93,498,478...93,510,494
|
|
G |
Capn6 |
calpain 6 |
decreases expression |
ISO |
Clobetasol results in decreased expression of CAPN6 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr X:107,380,774...107,405,489
Ensembl chr X:107,380,774...107,405,489
|
|
G |
Capza1 |
capping actin protein of muscle Z-line subunit alpha 1 |
increases expression |
ISO |
Clobetasol results in increased expression of CAPZA1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:192,319,696...192,364,755
Ensembl chr 2:192,319,702...192,364,480
|
|
G |
Car8 |
carbonic anhydrase 8 |
decreases expression |
ISO |
Clobetasol results in decreased expression of CAR8 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:21,302,940...21,402,395
Ensembl chr 5:21,305,383...21,402,374
|
|
G |
Caskin2 |
cask-interacting protein 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of CASKIN2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:101,027,196...101,041,429
Ensembl chr10:101,027,260...101,041,414
|
|
G |
Casp3 |
caspase 3 |
increases activity |
ISO |
Clobetasol results in increased activity of CASP3 protein |
CTD |
PMID:15086553 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp6 |
caspase 6 |
increases expression |
ISO |
Clobetasol results in increased expression of CASP6 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
|
|
G |
Cbr3 |
carbonyl reductase 3 |
increases expression |
ISO |
Clobetasol results in increased expression of CBR3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr11:33,008,615...33,016,877
Ensembl chr11:33,008,615...33,016,875
|
|
G |
Cc2d1a |
coiled-coil and C2 domain containing 1A |
decreases expression |
ISO |
Clobetasol results in decreased expression of CC2D1A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr19:24,011,897...24,026,937
Ensembl chr19:24,011,938...24,026,936
|
|
G |
Cc2d2a |
coiled-coil and C2 domain containing 2A |
decreases expression |
ISO |
Clobetasol results in decreased expression of CC2D2A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr14:67,349,004...67,435,883
Ensembl chr14:67,351,353...67,435,949
|
|
G |
Ccdc88a |
coiled coil domain containing 88A |
decreases expression |
ISO |
Clobetasol results in decreased expression of CCDC88A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr14:103,104,091...103,256,112
Ensembl chr14:103,103,513...103,252,368
|
|
G |
Ccdc88c |
coiled-coil domain containing 88C |
decreases expression |
ISO |
Clobetasol results in decreased expression of CCDC88C mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 6:120,169,752...120,289,459
Ensembl chr 6:120,169,738...120,289,555
|
|
G |
Ccn2 |
cellular communication network factor 2 |
increases expression |
ISO |
Clobetasol results in increased expression of CCN2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccs |
copper chaperone for superoxide dismutase |
increases expression |
ISO |
Clobetasol results in increased expression of CCS mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:202,113,792...202,134,931
Ensembl chr 1:202,113,804...202,134,915
|
|
G |
Cct2 |
chaperonin containing TCP1 subunit 2 |
increases expression |
ISO |
Clobetasol results in increased expression of CCT2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:52,692,725...52,705,478
Ensembl chr 7:52,692,725...52,706,944
|
|
G |
Cct3 |
chaperonin containing TCP1 subunit 3 |
increases expression |
ISO |
Clobetasol results in increased expression of CCT3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:173,765,701...173,790,353
Ensembl chr 2:173,765,698...173,790,757
|
|
G |
Cct7 |
chaperonin containing TCP1 subunit 7 |
increases expression |
ISO |
Clobetasol results in increased expression of CCT7 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:117,989,232...118,006,478
Ensembl chr 4:117,989,232...118,006,580
|
|
G |
Cd109 |
CD109 molecule |
increases expression |
ISO |
Clobetasol results in increased expression of CD109 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:79,454,480...79,569,195
Ensembl chr 8:79,454,480...79,569,194
|
|
G |
Cd40 |
CD40 molecule |
decreases expression |
ISO |
Clobetasol results in decreased expression of CD40 protein |
CTD |
PMID:15086553 |
|
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cd80 |
Cd80 molecule |
decreases expression |
ISO |
Clobetasol results in decreased expression of CD80 protein |
CTD |
PMID:15086553 |
|
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
|
|
G |
Cd81 |
Cd81 molecule |
increases expression |
ISO |
Clobetasol results in increased expression of CD81 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:198,235,861...198,251,660
Ensembl chr 1:198,241,484...198,251,660
|
|
G |
Cd86 |
CD86 molecule |
decreases expression |
ISO |
Clobetasol results in decreased expression of CD86 protein |
CTD |
PMID:15086553 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cdc42bpb |
CDC42 binding protein kinase beta |
decreases expression |
ISO |
Clobetasol results in decreased expression of CDC42BPB mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 6:130,333,712...130,416,631
Ensembl chr 6:130,333,712...130,416,377
|
|
G |
Cdc42ep1 |
CDC42 effector protein 1 |
increases expression |
ISO |
Clobetasol results in increased expression of CDC42EP1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:110,395,287...110,403,203
Ensembl chr 7:110,395,332...110,403,200
|
|
G |
Cdca7 |
cell division cycle associated 7 |
increases expression |
ISO |
Clobetasol results in increased expression of CDCA7 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:57,322,718...57,333,353
Ensembl chr 3:57,322,708...57,333,353
|
|
G |
Cdh13 |
cadherin 13 |
increases expression |
ISO |
Clobetasol results in increased expression of CDH13 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr19:46,349,562...47,387,462
Ensembl chr19:46,349,430...47,387,459
|
|
G |
Cdh4 |
cadherin 4 |
decreases expression |
ISO |
Clobetasol results in decreased expression of CDH4 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:166,525,092...167,003,380
Ensembl chr 3:166,525,099...167,003,371
|
|
G |
Cdk5 |
cyclin-dependent kinase 5 |
increases expression |
ISO |
Clobetasol results in increased expression of CDK5 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:10,754,682...10,760,110
Ensembl chr 4:10,754,687...10,760,112
|
|
G |
Cdkl5 |
cyclin-dependent kinase-like 5 |
increases expression |
ISO |
Clobetasol results in increased expression of CDKL5 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr X:33,757,605...33,988,075
Ensembl chr X:33,821,257...33,986,582
|
|
G |
Cdkn2aipnl |
CDKN2A interacting protein N-terminal like |
increases expression |
ISO |
Clobetasol results in increased expression of CDKN2AIPNL mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:36,231,134...36,240,569
Ensembl chr10:36,231,087...36,240,564
|
|
G |
Cdr2 |
cerebellar degeneration-related protein 2 |
increases expression |
ISO |
Clobetasol results in increased expression of CDR2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:175,502,837...175,527,746
Ensembl chr 1:175,502,838...175,537,472
|
|
G |
Cecr2 |
CECR2, histone acetyl-lysine reader |
decreases expression |
ISO |
Clobetasol results in decreased expression of CECR2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:153,890,310...153,998,078
Ensembl chr 4:153,890,206...153,993,451
|
|
G |
Celsr1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of CELSR1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:116,987,616...117,125,035
Ensembl chr 7:116,987,605...117,125,164
|
|
G |
Cenpe |
centromere protein E |
decreases expression |
ISO |
Clobetasol results in decreased expression of CENPE mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:223,637,035...223,695,692
Ensembl chr 2:223,636,998...223,695,669
|
|
G |
Cenpf |
centromere protein F |
decreases expression |
ISO |
Clobetasol results in decreased expression of CENPF mRNA |
CTD |
PMID:27462272 |
|
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
|
|
G |
Cep131 |
centrosomal protein 131 |
decreases expression |
ISO |
Clobetasol results in decreased expression of CEP131 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:105,346,015...105,370,380
Ensembl chr10:105,346,015...105,370,380
|
|
G |
Cep350 |
centrosomal protein 350 |
decreases expression |
ISO |
Clobetasol results in decreased expression of CEP350 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr13:68,023,327...68,164,478
Ensembl chr13:68,026,891...68,165,214
|
|
G |
Cfl1 |
cofilin 1 |
increases expression |
ISO |
Clobetasol results in increased expression of CFL1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
|
|
G |
Cftr |
CF transmembrane conductance regulator |
increases expression |
ISO |
Clobetasol results in increased expression of CFTR mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
|
|
G |
Chchd2 |
coiled-coil-helix-coiled-coil-helix domain containing 2 |
increases expression |
ISO |
Clobetasol results in increased expression of CHCHD2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:26,828,738...26,834,762
Ensembl chr12:26,828,736...26,834,755
|
|
G |
Chd2 |
chromodomain helicase DNA binding protein 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of CHD2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:127,188,146...127,317,041
Ensembl chr 1:127,190,059...127,300,502
|
|
G |
Chd3 |
chromodomain helicase DNA binding protein 3 |
decreases expression |
ISO |
Clobetasol results in decreased expression of CHD3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:54,063,629...54,090,030
Ensembl chr10:54,063,629...54,090,047
|
|
G |
Chd7 |
chromodomain helicase DNA binding protein 7 |
decreases expression |
ISO |
Clobetasol results in decreased expression of CHD7 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:21,812,007...21,995,358
Ensembl chr 5:21,812,070...21,995,358
|
|
G |
Chd8 |
chromodomain helicase DNA binding protein 8 |
decreases expression |
ISO |
Clobetasol results in decreased expression of CHD8 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr15:24,905,789...24,965,461
Ensembl chr15:24,905,789...24,951,285
|
|
G |
Chmp7 |
charged multivesicular body protein 7 |
increases expression |
ISO |
Clobetasol results in increased expression of CHMP7 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr15:44,790,983...44,806,216
Ensembl chr15:44,790,996...44,806,216
|
|
G |
Chst2 |
carbohydrate sulfotransferase 2 |
increases expression |
ISO |
Clobetasol results in increased expression of CHST2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:95,960,067...95,966,312
Ensembl chr 8:95,959,826...95,966,955
|
|
G |
Chst3 |
carbohydrate sulfotransferase 3 |
decreases expression |
ISO |
Clobetasol results in decreased expression of CHST3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr20:28,114,386...28,152,046
Ensembl chr20:28,114,404...28,121,807
|
|
G |
Ciao2b |
cytosolic iron-sulfur assembly component 2B |
increases expression |
ISO |
Clobetasol results in increased expression of CIAO2B mRNA |
CTD |
PMID:27462272 |
|
NCBI chr19:344,194...346,068
Ensembl chr19:344,203...346,068
|
|
G |
Ciapin1 |
cytokine induced apoptosis inhibitor 1 |
increases expression |
ISO |
Clobetasol results in increased expression of CIAPIN1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr19:10,179,963...10,195,511
Ensembl chr19:10,180,100...10,195,503
|
|
G |
Cisd1 |
CDGSH iron sulfur domain 1 |
increases expression |
ISO |
Clobetasol results in increased expression of CISD1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr20:17,255,302...17,268,688
Ensembl chr20:17,255,151...17,284,924
|
|
G |
Ckb |
creatine kinase B |
increases expression |
ISO |
Clobetasol results in increased expression of CKB mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
|
|
G |
Cks1b |
CDC28 protein kinase regulatory subunit 1B |
increases expression |
ISO |
Clobetasol results in increased expression of CKS1B mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:174,833,025...174,837,614
Ensembl chr 2:174,833,050...174,837,636
|
|
G |
Clasp2 |
cytoplasmic linker associated protein 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of CLASP2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:113,677,345...113,859,957
Ensembl chr 8:113,677,284...113,858,731
|
|
G |
Clip3 |
CAP-GLY domain containing linker protein 3 |
decreases expression |
ISO |
Clobetasol results in decreased expression of CLIP3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:85,547,170...85,563,187
Ensembl chr 1:85,547,206...85,563,184
|
|
G |
Clpp |
caseinolytic mitochondrial matrix peptidase proteolytic subunit |
increases expression |
ISO |
Clobetasol results in increased expression of CLPP mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:1,831,680...1,837,700
Ensembl chr 9:1,830,311...1,837,693
|
|
G |
Clptm1 |
CLPTM1 regulator of GABA type A receptor forward trafficking |
increases expression |
ISO |
Clobetasol results in increased expression of CLPTM1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:79,289,478...79,321,079
Ensembl chr 1:79,289,477...79,321,092
|
|
G |
Clptm1l |
CLPTM1-like |
increases expression |
ISO |
Clobetasol results in increased expression of CLPTM1L mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:29,667,545...29,683,530
Ensembl chr 1:29,667,545...29,683,530
|
|
G |
Clybl |
citramalyl-CoA lyase |
increases expression |
ISO |
Clobetasol results in increased expression of CLYBL mRNA |
CTD |
PMID:27462272 |
|
NCBI chr15:99,283,644...99,505,697
Ensembl chr15:99,283,650...99,505,695
|
|
G |
Cmss1 |
cms1 ribosomal small subunit homolog |
increases expression |
ISO |
Clobetasol results in increased expression of CMSS1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr11:42,934,390...43,232,624
Ensembl chr11:42,934,440...43,232,624
|
|
G |
Coa3 |
cytochrome C oxidase assembly factor 3 |
increases expression |
ISO |
Clobetasol results in increased expression of COA3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:86,220,192...86,221,173
Ensembl chr10:86,220,194...86,221,178
|
|
G |
Col11a1 |
collagen type XI alpha 1 chain |
decreases expression |
ISO |
Clobetasol results in decreased expression of COL11A1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:201,820,715...202,013,853
Ensembl chr 2:201,820,715...202,013,853
|
|
G |
Col12a1 |
collagen type XII alpha 1 chain |
decreases expression |
ISO |
Clobetasol results in decreased expression of COL12A1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:80,547,592...80,665,665
Ensembl chr 8:80,547,593...80,665,686
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
decreases expression |
ISO |
Clobetasol results in decreased expression of COL3A1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Col4a2 |
collagen type IV alpha 2 chain |
decreases expression |
ISO |
Clobetasol results in decreased expression of COL4A2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr16:78,047,591...78,183,360
Ensembl chr16:78,047,602...78,183,839
|
|
G |
Col5a1 |
collagen type V alpha 1 chain |
decreases expression |
ISO |
Clobetasol results in decreased expression of COL5A1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
|
|
G |
Col9a1 |
collagen type IX alpha 1 chain |
decreases expression |
ISO |
Clobetasol results in decreased expression of COL9A1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:26,585,034...26,668,222
Ensembl chr 9:26,585,034...26,668,213
|
|
G |
Copb1 |
COPI coat complex subunit beta 1 |
increases expression |
ISO |
Clobetasol results in increased expression of COPB1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:168,404,334...168,438,589
Ensembl chr 1:168,404,335...168,438,416
|
|
G |
Cope |
COPI coat complex subunit epsilon |
increases expression |
ISO |
Clobetasol results in increased expression of COPE mRNA |
CTD |
PMID:27462272 |
|
NCBI chr16:19,114,871...19,125,076
Ensembl chr16:19,114,871...19,128,907
|
|
G |
Cops8 |
COP9 signalosome subunit 8 |
increases expression |
ISO |
Clobetasol results in increased expression of COPS8 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:91,207,427...91,217,258
Ensembl chr 9:91,207,395...91,217,258
|
|
G |
Cotl1 |
coactosin-like F-actin binding protein 1 |
increases expression |
ISO |
Clobetasol results in increased expression of COTL1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr19:47,871,689...47,906,010
Ensembl chr19:47,871,694...47,911,689
|
|
G |
Cox14 |
cytochrome c oxidase assembly factor COX14 |
increases expression |
ISO |
Clobetasol results in increased expression of COX14 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:130,852,226...130,854,316
|
|
G |
Cox17 |
cytochrome c oxidase copper chaperone COX17 |
increases expression |
ISO |
Clobetasol results in increased expression of COX17 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr11:62,400,733...62,406,507
|
|
G |
Cox19 |
cytochrome c oxidase assembly factor COX19 |
increases expression |
ISO |
Clobetasol results in increased expression of COX19 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:15,303,535...15,313,014
Ensembl chr12:15,303,551...15,313,014
|
|
G |
Cox5a |
cytochrome c oxidase subunit 5A |
increases expression |
ISO |
Clobetasol results in increased expression of COX5A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:57,922,374...57,933,781
Ensembl chr 8:57,922,290...57,933,781
|
|
G |
Cox6a1 |
cytochrome c oxidase subunit 6A1 |
increases expression |
ISO |
Clobetasol results in increased expression of COX6A1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:41,261,983...41,265,037
Ensembl chr12:41,261,967...41,265,041
|
|
G |
Cox8a |
cytochrome c oxidase subunit 8A |
increases expression |
ISO |
Clobetasol results in increased expression of COX8A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:204,402,118...204,404,439
|
|
G |
Cpe |
carboxypeptidase E |
increases expression |
ISO |
Clobetasol results in increased expression of CPE mRNA |
CTD |
PMID:27462272 |
|
NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233
|
|
G |
Cplane1 |
ciliogenesis and planar polarity effector complex subunit 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of CPLANE1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:57,269,195...57,369,580
Ensembl chr 2:57,268,884...57,369,500
|
|
G |
Crb2 |
crumbs cell polarity complex component 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of CRB2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:21,542,138...21,564,876
Ensembl chr 3:21,542,221...21,563,294
|
|
G |
Creb3 |
cAMP responsive element binding protein 3 |
increases expression |
ISO |
Clobetasol results in increased expression of CREB3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:57,817,865...57,823,233
Ensembl chr 5:57,817,832...57,824,390
|
|
G |
Crebbp |
CREB binding protein |
decreases expression |
ISO |
Clobetasol results in decreased expression of CREBBP mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Creld1 |
cysteine-rich with EGF-like domains 1 |
increases expression |
ISO |
Clobetasol results in increased expression of CRELD1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:146,631,883...146,641,493
Ensembl chr 4:146,631,883...146,641,499
|
|
G |
Creld2 |
cysteine-rich with EGF-like domains 2 |
increases expression |
ISO |
Clobetasol results in increased expression of CRELD2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:119,909,626...119,916,556
Ensembl chr 7:119,909,633...119,916,543
|
|
G |
Crtc3 |
CREB regulated transcription coactivator 3 |
decreases expression |
ISO |
Clobetasol results in decreased expression of CRTC3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:134,552,830...134,655,929
Ensembl chr 1:134,554,696...134,655,500
|
|
G |
Cry1 |
cryptochrome circadian regulator 1 |
increases expression |
ISO |
Clobetasol results in increased expression of CRY1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091
|
|
G |
Cs |
citrate synthase |
increases expression |
ISO |
Clobetasol results in increased expression of CS mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
|
|
G |
Csad |
cysteine sulfinic acid decarboxylase |
increases expression |
ISO |
Clobetasol results in increased expression of CSAD mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:133,308,571...133,337,914
Ensembl chr 7:133,308,574...133,337,615
|
|
G |
Csdc2 |
cold shock domain containing C2 |
increases expression |
ISO |
Clobetasol results in increased expression of CSDC2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:113,451,998...113,466,464
Ensembl chr 7:113,451,998...113,466,463
|
|
G |
Csf2 |
colony stimulating factor 2 |
decreases secretion |
ISO |
Clobetasol results in decreased secretion of CSF2 protein |
CTD |
PMID:15086553 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Csnk2a1 |
casein kinase 2 alpha 1 |
increases expression |
ISO |
Clobetasol results in increased expression of CSNK2A1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:140,709,984...140,756,757
Ensembl chr 3:140,709,991...140,756,696
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
increases expression |
ISO |
Clobetasol results in increased expression of CSRP1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr13:47,158,171...47,179,388
Ensembl chr13:47,167,789...47,179,384
|
|
G |
Csrp2 |
cysteine and glycine-rich protein 2 |
increases expression |
ISO |
Clobetasol results in increased expression of CSRP2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:46,349,109...46,367,743
Ensembl chr 7:46,348,686...46,367,745
|
|
G |
Ctnnal1 |
catenin alpha-like 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of CTNNAL1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:71,514,340...71,569,431
Ensembl chr 5:71,514,340...71,569,431
|
|
G |
Ctsb |
cathepsin B |
increases expression |
ISO |
Clobetasol results in increased expression of CTSB mRNA |
CTD |
PMID:27462272 |
|
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Ctso |
cathepsin O |
increases expression |
ISO |
Clobetasol results in increased expression of CTSO mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:167,230,407...167,254,761
Ensembl chr 2:167,230,330...167,253,702
|
|
G |
Cuedc1 |
CUE domain containing 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of CUEDC1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:72,892,637...72,986,546
Ensembl chr10:72,892,637...72,986,542
|
|
G |
Cux2 |
cut-like homeobox 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of CUX2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:34,507,723...34,707,581
Ensembl chr12:34,520,959...34,705,806
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
increases expression |
ISO |
Clobetasol results in increased expression of CXCL12 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cycs |
cytochrome c, somatic |
increases expression |
ISO |
Clobetasol results in increased expression of CYCS mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression multiple interactions |
ISO |
Clobetasol results in increased expression of CYP1A1 mRNA Tretinoin inhibits the reaction [Clobetasol results in increased expression of CYP1A1 mRNA] |
CTD |
PMID:7697808 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[Clobetasol results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA |
CTD |
PMID:25455453 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
increases expression |
ISO |
Clobetasol results in increased expression of CYP3A5 mRNA |
CTD |
PMID:16882163 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
increases expression |
ISO |
Clobetasol results in increased expression of CYP51 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410 Ensembl chr 6:30,036,865...30,055,410
|
|
G |
Daam2 |
dishevelled associated activator of morphogenesis 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of DAAM2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:11,428,913...11,546,982
Ensembl chr 9:11,428,724...11,545,497
|
|
G |
Dad1 |
defender against cell death 1 |
increases expression |
ISO |
Clobetasol results in increased expression of DAD1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr15:27,677,286...27,697,120
Ensembl chr15:27,677,268...27,697,347
|
|
G |
Dazap2 |
DAZ associated protein 2 |
increases expression |
ISO |
Clobetasol results in increased expression of DAZAP2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:131,714,749...131,720,266
Ensembl chr 7:131,714,745...131,720,265
|
|
G |
Dcaf12 |
DDB1 and CUL4 associated factor 12 |
increases expression |
ISO |
Clobetasol results in increased expression of DCAF12 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:56,460,418...56,482,171
Ensembl chr 5:56,461,006...56,482,456
|
|
G |
Dcdc2 |
doublecortin domain containing 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of DCDC2A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr17:39,845,952...40,031,781
Ensembl chr17:39,845,952...40,030,743
|
|
G |
Dchs1 |
dachsous cadherin-related 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of DCHS1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:160,104,931...160,138,958
Ensembl chr 1:160,104,931...160,124,808
|
|
G |
Dck |
deoxycytidine kinase |
increases expression |
ISO |
Clobetasol results in increased expression of DCK mRNA |
CTD |
PMID:27462272 |
|
NCBI chr14:19,305,218...19,326,247
Ensembl chr14:19,305,218...19,326,247
|
|
G |
Ddb1 |
damage-specific DNA binding protein 1 |
increases expression |
ISO |
Clobetasol results in increased expression of DDB1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:207,252,890...207,278,685
Ensembl chr 1:207,252,890...207,278,676
|
|
G |
Ddt |
D-dopachrome tautomerase |
increases expression |
ISO |
Clobetasol results in increased expression of DDT mRNA |
CTD |
PMID:27462272 |
|
NCBI chr20:12,884,216...12,886,687
Ensembl chr20:12,884,243...12,888,482
|
|
G |
Degs1 |
delta(4)-desaturase, sphingolipid 1 |
increases expression |
ISO |
Clobetasol results in increased expression of DEGS1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr13:93,946,154...93,953,677
Ensembl chr13:93,946,157...93,953,664
|
|
G |
Derl1 |
derlin 1 |
increases expression |
ISO |
Clobetasol results in increased expression of DERL1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:89,404,413...89,427,095
Ensembl chr 7:89,404,417...89,427,145
|
|
G |
Dgkk |
diacylglycerol kinase kappa |
decreases expression |
ISO |
Clobetasol results in decreased expression of DGKK mRNA |
CTD |
PMID:27462272 |
|
NCBI chr X:15,581,991...15,713,814
Ensembl chr X:15,583,572...15,712,987
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
increases expression |
ISO |
Clobetasol results in increased expression of DHCR24 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
increases expression |
ISO |
Clobetasol results in increased expression of DHCR7 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dhfr |
dihydrofolate reductase |
decreases expression |
ISO |
Clobetasol results in decreased expression of DHFR mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
decreases expression |
ISO |
Clobetasol results in decreased expression of DIABLO mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
|
|
G |
Dido1 |
death inducer-obliterator 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of DIDO1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:167,772,535...167,825,894
Ensembl chr 3:167,772,770...167,817,218
|
|
G |
Dlgap4 |
DLG associated protein 4 |
decreases expression |
ISO |
Clobetasol results in decreased expression of DLGAP4 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:145,124,189...145,271,791
Ensembl chr 3:145,175,479...145,270,490
|
|
G |
Dll3 |
delta like canonical Notch ligand 3 |
increases expression |
ISO |
Clobetasol results in increased expression of DLL3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:83,562,011...83,570,008
Ensembl chr 1:83,562,014...83,569,750
|
|
G |
Dnaaf3 |
dynein, axonemal, assembly factor 3 |
increases expression |
ISO |
Clobetasol results in increased expression of DNAAF3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:69,291,300...69,299,365
Ensembl chr 1:69,291,454...69,299,344
|
|
G |
Dnajb11 |
DnaJ heat shock protein family (Hsp40) member B11 |
increases expression |
ISO |
Clobetasol results in increased expression of DNAJB11 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr11:78,151,750...78,168,259
Ensembl chr11:78,150,429...78,180,407
|
|
G |
Dnajc3 |
DnaJ heat shock protein family (Hsp40) member C3 |
increases expression |
ISO |
Clobetasol results in increased expression of DNAJC3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr15:96,025,605...96,068,585
Ensembl chr15:96,025,624...96,065,181
|
|
G |
Dnm3 |
dynamin 3 |
decreases expression |
ISO |
Clobetasol results in decreased expression of DNM3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr13:74,359,043...74,838,135
Ensembl chr13:74,359,213...74,838,108
|
|
G |
Dnph1 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of DNPH1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:14,481,296...14,484,034
Ensembl chr 9:14,481,066...14,484,022
|
|
G |
Dpysl2 |
dihydropyrimidinase-like 2 |
increases expression |
ISO |
Clobetasol results in increased expression of DPYSL2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr15:41,005,551...41,111,724
Ensembl chr15:41,005,551...41,111,829
|
|
G |
Dpysl4 |
dihydropyrimidinase-like 4 |
decreases expression |
ISO |
Clobetasol results in decreased expression of DPYSL4 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:193,883,039...193,898,916
Ensembl chr 1:193,883,106...193,898,914
|
|
G |
Draxin |
dorsal inhibitory axon guidance protein |
decreases expression |
ISO |
Clobetasol results in decreased expression of DRAXIN mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:158,530,149...158,563,457
Ensembl chr 5:158,530,342...158,564,483
|
|
G |
Dscam |
DS cell adhesion molecule |
decreases expression |
ISO |
Clobetasol results in decreased expression of DSCAM mRNA |
CTD |
PMID:27462272 |
|
NCBI chr11:35,921,924...36,507,100
Ensembl chr11:35,926,896...36,507,415
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
increases expression |
ISO |
Clobetasol results in increased expression of DUSP6 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
Dvl3 |
dishevelled segment polarity protein 3 |
decreases expression |
ISO |
Clobetasol results in decreased expression of DVL3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr11:80,365,446...80,382,641
Ensembl chr11:80,366,117...80,382,462
|
|
G |
Dync1h1 |
dynein cytoplasmic 1 heavy chain 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of DYNC1H1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 6:129,615,208...129,680,888
Ensembl chr 6:129,609,397...129,680,883
|
|
G |
Dynlt1 |
dynein light chain Tctex-type 1 |
increases expression |
ISO |
Clobetasol results in increased expression of DYNLT1B mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:46,887,017...46,893,956
Ensembl chr 1:46,887,017...46,893,881
|
|
G |
Ebp |
EBP, cholestenol delta-isomerase |
increases expression |
ISO |
Clobetasol results in increased expression of EBP mRNA |
CTD |
PMID:27462272 |
|
NCBI chr X:14,299,427...14,305,826
Ensembl chr X:14,299,448...14,305,826
|
|
G |
Edf1 |
endothelial differentiation-related factor 1 |
increases expression |
ISO |
Clobetasol results in increased expression of EDF1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:8,377,058...8,381,363
Ensembl chr 3:8,366,613...8,381,363
|
|
G |
Eea1 |
early endosome antigen 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of EEA1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:30,554,686...30,722,186
Ensembl chr 7:30,554,552...30,718,487
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
increases expression |
ISO |
Clobetasol results in increased expression of EEF2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
|
|
G |
Eif2b2 |
eukaryotic translation initiation factor 2B subunit beta |
increases expression |
ISO |
Clobetasol results in increased expression of EIF2B2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 6:104,866,926...104,873,351
Ensembl chr 6:104,866,753...104,873,353
|
|
G |
Eif3g |
eukaryotic translation initiation factor 3, subunit G |
increases expression |
ISO |
Clobetasol results in increased expression of EIF3G mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:19,429,728...19,433,760
Ensembl chr 8:19,429,643...19,433,808
|
|
G |
Eif3i |
eukaryotic translation initiation factor 3, subunit I |
increases expression |
ISO |
Clobetasol results in increased expression of EIF3I mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:141,935,135...141,942,589
Ensembl chr 5:141,935,044...141,942,676
|
|
G |
Eif4a3 |
eukaryotic translation initiation factor 4A3 |
increases expression |
ISO |
Clobetasol results in increased expression of EIF4A3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:104,549,038...104,559,032
Ensembl chr10:104,549,038...104,559,057
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
increases expression |
ISO |
Clobetasol results in increased expression of EIF4EBP1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Eif5b |
eukaryotic translation initiation factor 5B |
decreases expression |
ISO |
Clobetasol results in decreased expression of EIF5B mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:40,222,769...40,277,482
Ensembl chr 9:40,222,898...40,277,482
|
|
G |
Eif6 |
eukaryotic translation initiation factor 6 |
increases expression |
ISO |
Clobetasol results in increased expression of EIF6 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:144,325,038...144,331,396
Ensembl chr 3:144,325,036...144,331,401
|
|
G |
Elavl3 |
ELAV like RNA binding protein 3 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ELAVL3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:20,547,108...20,583,369
Ensembl chr 8:20,550,201...20,583,641
|
|
G |
Elfn1 |
extracellular leucine-rich repeat and fibronectin type III domain containing 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ELFN1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:14,660,049...14,725,709
Ensembl chr12:14,660,083...14,724,580
|
|
G |
Elovl5 |
ELOVL fatty acid elongase 5 |
increases expression |
ISO |
Clobetasol results in increased expression of ELOVL5 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:78,790,846...78,857,307
Ensembl chr 8:78,790,846...78,857,284
|
|
G |
Emc4 |
ER membrane protein complex subunit 4 |
increases expression |
ISO |
Clobetasol results in increased expression of EMC4 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:99,169,711...99,174,730
Ensembl chr 3:99,169,711...99,174,729
|
|
G |
Emc7 |
ER membrane protein complex subunit 7 |
increases expression |
ISO |
Clobetasol results in increased expression of EMC7 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:99,263,933...99,274,365
Ensembl chr 3:99,263,980...99,274,360
|
|
G |
Emg1 |
EMG1 N1-specific pseudouridine methyltransferase |
increases expression |
ISO |
Clobetasol results in increased expression of EMG1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:157,509,258...157,517,540
Ensembl chr 4:157,509,277...157,517,540
|
|
G |
Entpd6 |
ectonucleoside triphosphate diphosphohydrolase 6 |
increases expression |
ISO |
Clobetasol results in increased expression of ENTPD6 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:139,575,659...139,598,163
Ensembl chr 3:139,575,686...139,598,154
|
|
G |
Ep300 |
E1A binding protein p300 |
decreases expression |
ISO |
Clobetasol results in decreased expression of EP300 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Epb41 |
erythrocyte membrane protein band 4.1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of EPB41 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:144,110,010...144,264,037
Ensembl chr 5:144,111,906...144,237,821
|
|
G |
Erg28 |
ergosterol biosynthesis 28 homolog |
increases expression |
ISO |
Clobetasol results in increased expression of ERG28 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 6:105,474,112...105,483,078
Ensembl chr 6:105,474,113...105,483,078
|
|
G |
Evpl |
envoplakin |
decreases expression |
ISO |
Clobetasol results in decreased expression of EVPL mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:101,458,227...101,474,778
Ensembl chr10:101,458,216...101,474,763
|
|
G |
Faap24 |
FA core complex associated protein 24 |
increases expression |
ISO |
Clobetasol results in increased expression of FAAP24 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:88,051,523...88,057,997
Ensembl chr 1:88,051,911...88,057,989
|
|
G |
Fabp7 |
fatty acid binding protein 7 |
increases expression |
ISO |
Clobetasol results in increased expression of FABP7 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr20:37,123,193...37,126,725
Ensembl chr20:37,123,193...37,126,880
|
|
G |
Fads1 |
fatty acid desaturase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of FADS1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734
|
|
G |
Fads2 |
fatty acid desaturase 2 |
increases expression |
ISO |
Clobetasol results in increased expression of FADS2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
|
|
G |
Fam184a |
family with sequence similarity 184, member A |
decreases expression |
ISO |
Clobetasol results in decreased expression of FAM184A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr20:32,934,424...33,056,626
Ensembl chr20:32,934,636...33,056,652
|
|
G |
Fam185a |
family with sequence similarity 185, member A |
decreases expression |
ISO |
Clobetasol results in decreased expression of FAM185A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:13,542,022...13,662,967
Ensembl chr 4:13,608,464...13,662,967
|
|
G |
Fam193a |
family with sequence similarity 193, member A |
decreases expression |
ISO |
Clobetasol results in decreased expression of FAM193A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr14:76,250,103...76,382,525
Ensembl chr14:76,256,161...76,382,514
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
Clobetasol results in increased expression of FAS protein |
CTD |
PMID:15086553 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fasn |
fatty acid synthase |
increases expression |
ISO |
Clobetasol results in increased expression of FASN mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fat1 |
FAT atypical cadherin 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of FAT1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr16:47,177,253...47,296,261
Ensembl chr16:47,177,248...47,296,107
|
|
G |
Fat3 |
FAT atypical cadherin 3 |
decreases expression |
ISO |
Clobetasol results in decreased expression of FAT3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:12,691,470...13,274,336
Ensembl chr 8:12,694,019...13,273,135
|
|
G |
Fbl |
fibrillarin |
increases expression |
ISO |
Clobetasol results in increased expression of FBL mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:83,469,832...83,478,932
Ensembl chr 1:83,469,832...83,478,932
|
|
G |
Fbxl18 |
F-box and leucine-rich repeat protein 18 |
decreases expression |
ISO |
Clobetasol results in decreased expression of FBXL18 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:11,674,538...11,701,317
Ensembl chr12:11,676,115...11,699,181
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of FDFT1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
|
|
G |
Fez1 |
fasciculation and elongation protein zeta 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of FEZ1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:36,544,462...36,589,684
Ensembl chr 8:36,544,535...36,589,683
|
|
G |
Flrt2 |
fibronectin leucine rich transmembrane protein 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of FLRT2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 6:114,777,547...114,872,688
Ensembl chr 6:114,777,599...114,872,785
|
|
G |
Flvcr2 |
FLVCR choline and putative heme transporter 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of FLVCR2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 6:105,408,355...105,472,355
Ensembl chr 6:105,408,339...105,472,353
|
|
G |
Fmc1 |
formation of mitochondrial complex V assembly factor 1 |
increases expression |
ISO |
Clobetasol results in increased expression of FMC1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:67,274,104...67,282,140
Ensembl chr 4:67,274,104...67,282,140
|
|
G |
Fmnl2 |
formin-like 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of FMNL2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:37,348,791...37,624,746
Ensembl chr 3:37,348,574...37,624,754
|
|
G |
Fnbp4 |
formin binding protein 4 |
decreases expression |
ISO |
Clobetasol results in decreased expression of FNBP4 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:76,733,012...76,763,077
Ensembl chr 3:76,733,027...76,763,079
|
|
G |
Fndc10 |
fibronectin type III domain containing 10 |
increases expression |
ISO |
Clobetasol results in increased expression of FNDC10 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:166,299,587...166,311,477
Ensembl chr 5:166,300,122...166,310,326
|
|
G |
Foxk1 |
forkhead box K1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of FOXK1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:12,110,119...12,175,089
Ensembl chr12:12,115,950...12,175,089
|
|
G |
Foxred1 |
FAD-dependent oxidoreductase domain containing 1 |
increases expression |
ISO |
Clobetasol results in increased expression of FOXRED1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:33,551,010...33,560,227
Ensembl chr 8:33,551,013...33,560,192
|
|
G |
Frmd8 |
FERM domain containing 8 |
increases expression |
ISO |
Clobetasol results in increased expression of FRMD8 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:203,143,216...203,163,868
Ensembl chr 1:203,143,218...203,163,870
|
|
G |
Frmpd1 |
FERM and PDZ domain containing 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of FRMPD1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:59,443,076...59,545,125
Ensembl chr 5:59,443,076...59,545,080
|
|
G |
Fry |
FRY microtubule binding protein |
increases expression |
ISO |
Clobetasol results in increased expression of FRY mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:4,493,890...4,887,118
Ensembl chr12:4,493,891...4,799,116
|
|
G |
Frzb |
frizzled-related protein |
increases expression |
ISO |
Clobetasol results in increased expression of FRZB mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:65,332,274...65,365,208
Ensembl chr 3:65,332,277...65,365,208
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression |
ISO |
Clobetasol results in increased expression of FTH1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Gabarapl2 |
GABA type A receptor associated protein like 2 |
increases expression |
ISO |
Clobetasol results in increased expression of GABARAPL2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr19:39,910,572...39,921,408
Ensembl chr19:39,910,534...39,924,628
|
|
G |
Gabbr2 |
gamma-aminobutyric acid type B receptor subunit 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of GABBR2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:60,947,517...61,288,104
Ensembl chr 5:60,947,526...61,288,104
|
|
G |
Galk1 |
galactokinase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of GALK1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:101,243,146...101,247,323
Ensembl chr10:101,235,994...101,247,337
|
|
G |
Gap43 |
growth associated protein 43 |
decreases expression |
ISO |
Clobetasol results in decreased expression of GAP43 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
|
|
G |
Gars1 |
glycyl-tRNA synthetase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of GARS1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
decreases expression |
ISO |
Clobetasol results in decreased expression of GCLC mRNA |
CTD |
PMID:16882163 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gcn1 |
GCN1 activator of EIF2AK4 |
decreases expression |
ISO |
Clobetasol results in decreased expression of GCN1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:40,991,512...41,052,661
Ensembl chr12:40,991,512...41,052,555
|
|
G |
Gcsh |
glycine cleavage system protein H |
increases expression |
ISO |
Clobetasol results in increased expression of GCSH mRNA |
CTD |
PMID:27462272 |
|
NCBI chr19:45,036,013...45,046,770
Ensembl chr19:45,036,011...45,046,792
|
|
G |
Gdf11 |
growth differentiation factor 11 |
decreases expression |
ISO |
Clobetasol results in decreased expression of GDF11 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:1,311,732...1,325,211
Ensembl chr 7:1,311,732...1,320,725
|
|
G |
Gdi1 |
GDP dissociation inhibitor 1 |
increases expression |
ISO |
Clobetasol results in increased expression of GDI1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr X:152,087,611...152,094,274
Ensembl chr X:152,087,444...152,094,272
|
|
G |
Gdpd3 |
glycerophosphodiester phosphodiesterase domain containing 3 |
increases expression |
ISO |
Clobetasol results in increased expression of GDPD3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:181,373,505...181,383,063
Ensembl chr 1:181,366,626...181,383,063
|
|
G |
Get3 |
guided entry of tail-anchored proteins factor 3, ATPase |
increases expression |
ISO |
Clobetasol results in increased expression of GET3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr19:23,130,109...23,138,196
Ensembl chr19:23,130,109...23,138,193
|
|
G |
Gfpt2 |
glutamine-fructose-6-phosphate transaminase 2 |
increases expression |
ISO |
Clobetasol results in increased expression of GFPT2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:34,115,005...34,161,329
Ensembl chr10:34,115,052...34,161,329
|
|
G |
Glmp |
glycosylated lysosomal membrane protein |
increases expression |
ISO |
Clobetasol results in increased expression of GLMP mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:173,794,273...173,797,863
Ensembl chr 2:173,794,255...173,799,960
|
|
G |
Glo1 |
glyoxalase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of GLO1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr20:8,663,617...8,681,661
Ensembl chr20:8,662,801...8,681,649
|
|
G |
Glrx3 |
glutaredoxin 3 |
increases expression |
ISO |
Clobetasol results in increased expression of GLRX3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:192,241,707...192,272,012
Ensembl chr 1:192,241,701...192,272,010
|
|
G |
Glrx5 |
glutaredoxin 5 |
increases expression |
ISO |
Clobetasol results in increased expression of GLRX5 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 6:123,988,461...123,998,545
Ensembl chr 6:123,988,134...123,998,545
|
|
G |
Glul |
glutamate-ammonia ligase |
increases expression |
ISO |
Clobetasol results in increased expression of GLUL mRNA |
CTD |
PMID:27462272 |
|
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
|
|
G |
Gm2a |
ganglioside GM2 activator |
increases expression |
ISO |
Clobetasol results in increased expression of GM2A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:39,219,221...39,231,756
Ensembl chr10:39,219,243...39,231,757
|
|
G |
Gmcl1 |
germ cell-less 1, spermatogenesis associated |
increases expression |
ISO |
Clobetasol results in increased expression of GMCL1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:119,140,598...119,179,891
Ensembl chr 4:119,140,598...119,179,881
|
|
G |
Gna13 |
G protein subunit alpha 13 |
increases expression |
ISO |
Clobetasol results in increased expression of GNA13 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:94,337,939...94,370,774
Ensembl chr10:94,337,725...94,370,774
|
|
G |
Gnai3 |
G protein subunit alpha i3 |
increases expression |
ISO |
Clobetasol results in increased expression of GNAI3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:195,742,765...195,780,720
Ensembl chr 2:195,742,642...195,780,742
|
|
G |
Gnb2 |
G protein subunit beta 2 |
increases expression |
ISO |
Clobetasol results in increased expression of GNB2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:19,159,002...19,164,021
Ensembl chr12:19,158,973...19,164,019
|
|
G |
Golgb1 |
golgin B1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of GOLGB1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr11:63,843,179...63,900,665
Ensembl chr11:63,843,986...63,900,770
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of GOT1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of GPD1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529
|
|
G |
Gper1 |
G protein-coupled estrogen receptor 1 |
increases expression |
ISO |
Clobetasol results in increased expression of GPER1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:15,217,217...15,222,679
Ensembl chr12:15,217,442...15,221,889
|
|
G |
Gpi |
glucose-6-phosphate isomerase |
increases expression |
ISO |
Clobetasol results in increased expression of GPI1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:86,828,211...86,856,077
Ensembl chr 1:86,828,216...86,856,086
|
|
G |
Gpr17 |
G protein-coupled receptor 17 |
decreases expression |
ISO |
Clobetasol results in decreased expression of GPR17 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr18:23,576,232...23,583,153
Ensembl chr18:23,577,242...23,582,966
|
|
G |
Gprc5b |
G protein-coupled receptor, class C, group 5, member B |
increases expression |
ISO |
Clobetasol results in increased expression of GPRC5B mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:173,316,904...173,340,933
Ensembl chr 1:173,316,907...173,340,932
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of GPX1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Grhpr |
glyoxylate and hydroxypyruvate reductase |
increases expression |
ISO |
Clobetasol results in increased expression of GRHPR mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:59,234,179...59,243,614
Ensembl chr 5:59,234,192...59,243,603
|
|
G |
Grik3 |
glutamate ionotropic receptor kainate type subunit 3 |
decreases expression |
ISO |
Clobetasol results in decreased expression of GRIK3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:137,767,865...137,989,617
Ensembl chr 5:137,767,865...137,984,307
|
|
G |
Grina |
glutamate ionotropic receptor NMDA type subunit associated protein 1 |
increases expression |
ISO |
Clobetasol results in increased expression of GRINA mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:107,962,194...107,965,372
Ensembl chr 7:107,962,207...107,965,366
|
|
G |
Grm3 |
glutamate metabotropic receptor 3 |
decreases expression |
ISO |
Clobetasol results in decreased expression of GRM3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:24,364,854...24,643,972
Ensembl chr 4:24,365,115...24,609,804
|
|
G |
Gsk3a |
glycogen synthase kinase 3 alpha |
increases expression |
ISO |
Clobetasol results in increased expression of GSK3A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:80,815,843...80,825,732
Ensembl chr 1:80,815,850...80,825,802
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases expression |
ISO |
Clobetasol results in increased expression of GSR mRNA |
CTD |
PMID:27462272 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
increases expression |
ISO |
Clobetasol results in increased expression of GSTM5 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
increases expression |
ISO |
Clobetasol results in increased expression of GSTP1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gtpbp1 |
GTP binding protein 1 |
increases expression |
ISO |
Clobetasol results in increased expression of GTPBP1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:111,248,254...111,272,705
Ensembl chr 7:111,248,254...111,272,705
|
|
G |
Gucy1a1 |
guanylate cyclase 1 soluble subunit alpha 1 |
increases expression |
ISO |
Clobetasol results in increased expression of GUCY1A1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:167,418,615...167,482,293
Ensembl chr 2:167,418,640...167,481,671
|
|
G |
H1f0 |
H1.0 linker histone |
increases expression |
ISO |
Clobetasol results in increased expression of H1F0 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:110,592,834...110,594,694
Ensembl chr 7:110,592,208...110,594,694
|
|
G |
H2aj |
H2A.J histone |
increases expression |
ISO |
Clobetasol results in increased expression of H2AJ mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:169,675,718...169,676,202
Ensembl chr 4:169,675,752...169,677,006
|
|
G |
Hars1 |
histidyl-tRNA synthetase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of HARS1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr18:28,381,649...28,398,699
Ensembl chr18:28,381,655...28,398,740
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
decreases expression |
ISO |
Clobetasol results in decreased expression of HBEGF mRNA |
CTD |
PMID:27462272 |
|
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
|
|
G |
Hcfc1 |
host cell factor C1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of HCFC1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr X:151,687,779...151,712,688
Ensembl chr X:151,687,779...151,712,638
|
|
G |
Hdac3 |
histone deacetylase 3 |
increases expression |
ISO |
Clobetasol results in increased expression of HDAC3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr18:29,770,637...29,789,850
Ensembl chr18:29,770,636...29,793,856
|
|
G |
Hectd4 |
HECT domain E3 ubiquitin protein ligase 4 |
decreases expression |
ISO |
Clobetasol results in decreased expression of HECTD4 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:35,182,165...35,330,935
Ensembl chr12:35,182,154...35,330,987
|
|
G |
Hepacam |
hepatic and glial cell adhesion molecule |
increases expression |
ISO |
Clobetasol results in increased expression of HEPACAM mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:37,087,864...37,106,759
Ensembl chr 8:37,087,857...37,105,920
|
|
G |
Herc1 |
HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of HERC1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:66,857,169...67,070,318
Ensembl chr 8:66,856,935...67,070,312
|
|
G |
Hip1r |
huntingtin interacting protein 1 related |
decreases expression |
ISO |
Clobetasol results in decreased expression of HIP1R mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:32,590,164...32,618,841
Ensembl chr12:32,590,165...32,618,734
|
|
G |
Hivep1 |
HIVEP zinc finger 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of HIVEP1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr17:22,585,016...22,714,517
Ensembl chr17:22,585,016...22,711,956
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
increases expression |
ISO |
Clobetasol results in increased expression of HMGCR mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hook3 |
hook microtubule-tethering protein 3 |
decreases expression |
ISO |
Clobetasol results in decreased expression of HOOK3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr16:65,954,293...66,058,812
Ensembl chr16:65,954,350...66,061,338
|
|
G |
Hoxa5 |
homeo box A5 |
decreases expression |
ISO |
Clobetasol results in decreased expression of HOXA5 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:81,302,341...81,306,234
Ensembl chr 4:81,302,353...81,306,234
|
|
G |
Hr |
HR, lysine demethylase and nuclear receptor corepressor |
decreases expression |
ISO |
Clobetasol results in decreased expression of HR mRNA |
CTD |
PMID:27462272 |
|
NCBI chr15:45,626,835...45,646,313
Ensembl chr15:45,626,835...45,646,313
|
|
G |
Hs3st1 |
heparan sulfate-glucosamine 3-sulfotransferase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of HS3ST1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr14:71,185,826...71,223,263
Ensembl chr14:71,185,682...71,223,248
|
|
G |
Hsd17b4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
increases expression |
ISO |
Clobetasol results in increased expression of HSD17B4 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr18:43,328,903...43,417,950
Ensembl chr18:43,328,824...43,417,952
|
|
G |
Hsd17b7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
increases expression |
ISO |
Clobetasol results in increased expression of HSD17B7 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr13:82,170,079...82,190,018
Ensembl chr13:82,173,179...82,190,017
|
|
G |
Hspe1 |
heat shock protein family E (Hsp10) member 1 |
increases expression |
ISO |
Clobetasol results in increased expression of HSPE1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:56,589,912...56,593,000
Ensembl chr 9:56,589,789...56,593,089
|
|
G |
Hspg2 |
heparan sulfate proteoglycan 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of HSPG2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:149,677,437...149,778,594
Ensembl chr 5:149,677,476...149,778,594
|
|
G |
Hypk |
Huntingtin interacting protein K |
increases expression |
ISO |
Clobetasol results in increased expression of HYPK mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:108,434,997...108,436,370
Ensembl chr 3:108,432,539...108,436,370
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ICAM1 protein |
CTD |
PMID:15086553 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Id1 |
inhibitor of DNA binding 1 |
increases expression |
ISO |
Clobetasol results in increased expression of ID1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
|
|
G |
Id3 |
inhibitor of DNA binding 3 |
increases expression |
ISO |
Clobetasol results in increased expression of ID3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
increases expression |
ISO |
Clobetasol results in increased expression of IDH2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
|
|
G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of IDI1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
|
|
G |
Ier3ip1 |
immediate early response 3 interacting protein 1 |
increases expression |
ISO |
Clobetasol results in increased expression of IER3IP1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr18:70,474,978...70,486,062
Ensembl chr18:70,474,926...70,526,470
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
increases expression |
ISO |
Clobetasol results in increased expression of IGFBP2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
increases expression |
ISO |
Clobetasol results in increased expression of IGFBP3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
|
|
G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
decreases expression |
ISO |
Clobetasol results in decreased expression of IGFBP5 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
|
|
G |
Igsf10 |
immunoglobulin superfamily, member 10 |
decreases expression |
ISO |
Clobetasol results in decreased expression of IGSF10 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:143,575,710...143,605,044
Ensembl chr 2:143,576,070...143,604,773
|
|
G |
Igsf9b |
immunoglobulin superfamily, member 9B |
decreases expression |
ISO |
Clobetasol results in decreased expression of IGSF9B mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:25,712,644...25,769,481
Ensembl chr 8:25,712,644...25,758,554
|
|
G |
Il1a |
interleukin 1 alpha |
decreases secretion |
ISO |
Clobetasol results in decreased secretion of IL1A protein |
CTD |
PMID:15086553 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
decreases expression |
ISO |
Clobetasol results in decreased expression of IL2RA protein |
CTD |
PMID:15086553 |
|
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
|
|
G |
Ilf2 |
interleukin enhancer binding factor 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ILF2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:175,952,174...175,971,191
Ensembl chr 2:175,952,186...175,971,337
|
|
G |
Imp3 |
IMP U3 small nucleolar ribonucleoprotein 3 |
increases expression |
ISO |
Clobetasol results in increased expression of IMP3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:57,339,528...57,340,416
Ensembl chr 8:57,339,496...57,340,414
|
|
G |
Impact |
impact RWD domain protein |
increases expression |
ISO |
Clobetasol results in increased expression of IMPACT mRNA |
CTD |
PMID:27462272 |
|
NCBI chr18:4,108,872...4,147,571
Ensembl chr18:4,108,853...4,147,569
|
|
G |
Impdh2 |
inosine monophosphate dehydrogenase 2 |
increases expression |
ISO |
Clobetasol results in increased expression of IMPDH2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:109,256,705...109,261,365
Ensembl chr 8:109,256,728...109,261,359
|
|
G |
Ino80 |
INO80 complex ATPase subunit |
decreases expression |
ISO |
Clobetasol results in decreased expression of INO80 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:106,368,455...106,465,716
Ensembl chr 3:106,368,455...106,467,911
|
|
G |
Insig1 |
insulin induced gene 1 |
increases expression |
ISO |
Clobetasol results in increased expression of INSIG1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
|
|
G |
Ints11 |
integrator complex subunit 11 |
increases expression |
ISO |
Clobetasol results in increased expression of INTS11 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:166,479,134...166,497,956
Ensembl chr 5:166,479,155...166,497,651
|
|
G |
Ints5 |
integrator complex subunit 5 |
increases expression |
ISO |
Clobetasol results in increased expression of INTS5 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:205,788,906...205,793,685
Ensembl chr 1:205,788,906...205,793,685
|
|
G |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of IQGAP2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:26,894,836...27,170,270
Ensembl chr 2:26,894,825...27,170,279
|
|
G |
Iqsec1 |
IQ motif and Sec7 domain ArfGEF 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of IQSEC1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:123,168,719...123,488,300
Ensembl chr 4:123,168,719...123,488,172
|
|
G |
Irs2 |
insulin receptor substrate 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of IRS2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr16:78,488,249...78,512,482
Ensembl chr16:78,485,045...78,512,482
|
|
G |
Itpa |
inosine triphosphatase |
increases expression |
ISO |
Clobetasol results in increased expression of ITPA mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:117,885,464...117,897,247
Ensembl chr 3:117,885,099...117,897,249
|
|
G |
Itsn1 |
intersectin 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ITSN1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr11:30,978,590...31,160,645
Ensembl chr11:30,978,590...31,160,645
|
|
G |
Ivd |
isovaleryl-CoA dehydrogenase |
increases expression |
ISO |
Clobetasol results in increased expression of IVD mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:105,851,710...105,872,144
Ensembl chr 3:105,851,683...105,872,575
|
|
G |
Iws1 |
interacts with SUPT6H, CTD assembly factor 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of IWS1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr18:23,695,496...23,737,363
Ensembl chr18:23,695,425...23,736,172
|
|
G |
Jak1 |
Janus kinase 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of JAK1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
|
|
G |
Jam3 |
junctional adhesion molecule 3 |
increases expression |
ISO |
Clobetasol results in increased expression of JAM3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:25,508,461...25,569,306
Ensembl chr 8:25,507,057...25,569,355
|
|
G |
Jmjd1c |
jumonji domain containing 1C |
decreases expression |
ISO |
Clobetasol results in decreased expression of JMJD1C mRNA |
CTD |
PMID:27462272 |
|
NCBI chr20:21,332,147...21,494,220
Ensembl chr20:21,332,147...21,463,122
|
|
G |
Jmjd8 |
jumonji domain containing 8 |
increases expression |
ISO |
Clobetasol results in increased expression of JMJD8 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:14,848,965...14,851,881
Ensembl chr10:14,848,980...14,851,879
|
|
G |
Jmy |
junction mediating and regulatory protein, p53 cofactor |
decreases expression |
ISO |
Clobetasol results in decreased expression of JMY mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:24,662,104...24,730,955
Ensembl chr 2:24,668,854...24,731,006
|
|
G |
Jpt1 |
Jupiter microtubule associated homolog 1 |
increases expression |
ISO |
Clobetasol results in increased expression of JPT1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:100,744,468...100,762,504
Ensembl chr10:100,686,797...100,784,513
|
|
G |
Kank4 |
KN motif and ankyrin repeat domains 4 |
decreases expression |
ISO |
Clobetasol results in decreased expression of KANK4 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:113,401,491...113,465,526
Ensembl chr 5:113,402,468...113,465,555
|
|
G |
Kazn |
kazrin, periplakin interacting protein |
decreases expression |
ISO |
Clobetasol results in decreased expression of KAZN mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:154,392,793...155,381,567
Ensembl chr 5:154,392,793...154,779,074
|
|
G |
Kcna2 |
potassium voltage-gated channel subfamily A member 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of KCNA2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:194,704,555...194,718,387
Ensembl chr 2:194,704,639...194,718,400
|
|
G |
Kcnmb4 |
potassium calcium-activated channel subfamily M regulatory beta subunit 4 |
increases expression |
ISO |
Clobetasol results in increased expression of KCNMB4 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:52,066,145...52,119,098
Ensembl chr 7:52,066,136...52,119,278
|
|
G |
Kcnt1 |
potassium sodium-activated channel subfamily T member 1 |
increases expression |
ISO |
Clobetasol results in increased expression of KCNT1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:8,682,964...8,736,615
Ensembl chr 3:8,682,113...8,736,667
|
|
G |
Kctd5 |
potassium channel tetramerization domain containing 5 |
increases expression |
ISO |
Clobetasol results in increased expression of KCTD5 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:13,079,216...13,105,197
Ensembl chr10:13,079,214...13,105,209
|
|
G |
Kdelr2 |
KDEL endoplasmic reticulum protein retention receptor 2 |
increases expression |
ISO |
Clobetasol results in increased expression of KDELR2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:11,138,820...11,157,117
Ensembl chr12:11,138,820...11,157,153
|
|
G |
Kdm6b |
lysine demethylase 6B |
decreases expression |
ISO |
Clobetasol results in decreased expression of KDM6B mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:54,120,716...54,142,212
Ensembl chr10:54,121,848...54,130,794
|
|
G |
Khdrbs1 |
KH RNA binding domain containing, signal transduction associated 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of KHDRBS1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:142,051,844...142,089,175
Ensembl chr 5:142,063,570...142,089,180
|
|
G |
Kif13a |
kinesin family member 13A |
decreases expression |
ISO |
Clobetasol results in decreased expression of KIF13A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr17:17,766,597...17,948,517
Ensembl chr17:17,766,597...17,943,615
|
|
G |
Kif5a |
kinesin family member 5A |
decreases expression |
ISO |
Clobetasol results in decreased expression of KIF5A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:63,051,894...63,089,024
Ensembl chr 7:63,049,424...63,092,858
|
|
G |
Kirrel2 |
kirre like nephrin family adhesion molecule 2 |
increases expression |
ISO |
Clobetasol results in increased expression of KIRREL2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:85,708,793...85,718,670
Ensembl chr 1:85,708,793...85,718,670
|
|
G |
Klf9 |
KLF transcription factor 9 |
increases expression |
ISO |
Clobetasol results in increased expression of KLF9 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:220,700,108...220,725,110
Ensembl chr 1:220,700,108...220,725,037
|
|
G |
Kmt2c |
lysine methyltransferase 2C |
decreases expression |
ISO |
Clobetasol results in decreased expression of KMT2C mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:9,620,638...9,834,787
Ensembl chr 4:9,609,627...9,833,539
|
|
G |
Kmt2d |
lysine methyltransferase 2D |
decreases expression |
ISO |
Clobetasol results in decreased expression of KMT2D mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:129,980,744...130,022,088
Ensembl chr 7:129,962,887...130,020,325
|
|
G |
Kmt2e |
lysine methyltransferase 2E |
decreases expression |
ISO |
Clobetasol results in decreased expression of KMT2E mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:11,658,218...11,727,373
Ensembl chr 4:11,658,979...11,727,373
|
|
G |
Knl1 |
kinetochore scaffold 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of KNL1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:106,029,627...106,091,915
Ensembl chr 3:106,029,661...106,091,915
|
|
G |
Krtcap2 |
keratinocyte associated protein 2 |
increases expression |
ISO |
Clobetasol results in increased expression of KRTCAP2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:174,654,409...174,658,405
Ensembl chr 2:174,654,219...174,658,405
|
|
G |
Kti12 |
KTI12 chromatin associated |
increases expression |
ISO |
Clobetasol results in increased expression of KTI12 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:123,601,059...123,602,581
Ensembl chr 5:123,599,436...123,613,964
|
|
G |
Lama1 |
laminin subunit alpha 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of LAMA1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:107,692,770...107,816,847
Ensembl chr 9:107,692,770...107,817,478
|
|
G |
Lamtor1 |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 1 |
increases expression |
ISO |
Clobetasol results in increased expression of LAMTOR1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:156,272,116...156,277,687
Ensembl chr 1:156,272,064...156,291,179
|
|
G |
Lamtor5 |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5 |
increases expression |
ISO |
Clobetasol results in increased expression of LAMTOR5 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:194,900,038...194,905,394
Ensembl chr 2:194,900,038...194,905,395
|
|
G |
Laptm4b |
lysosomal protein transmembrane 4 beta |
increases expression |
ISO |
Clobetasol results in increased expression of LAPTM4B mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:65,434,525...65,477,386
Ensembl chr 7:65,434,394...65,477,383
|
|
G |
Larp1 |
La ribonucleoprotein 1, translational regulator |
decreases expression |
ISO |
Clobetasol results in decreased expression of LARP1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:42,191,378...42,246,361
Ensembl chr10:42,191,325...42,243,371
|
|
G |
Lbh |
LBH regulator of WNT signaling pathway |
increases expression |
ISO |
Clobetasol results in increased expression of LBH mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 6:22,569,238...22,593,056
Ensembl chr 6:22,568,834...22,593,079
|
|
G |
Leng8 |
leukocyte receptor cluster member 8 |
decreases expression |
ISO |
Clobetasol results in decreased expression of LENG8 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:70,040,785...70,052,662
Ensembl chr 1:70,040,785...70,052,488
|
|
G |
Lfng |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
increases expression |
ISO |
Clobetasol results in increased expression of LFNG mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:14,030,551...14,038,996
Ensembl chr12:14,018,333...14,039,008
|
|
G |
Lgals1 |
galectin 1 |
increases expression |
ISO |
Clobetasol results in increased expression of LGALS1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:110,485,239...110,488,345
Ensembl chr 7:110,481,392...110,488,345
|
|
G |
Lgalsl |
galectin-like |
increases expression |
ISO |
Clobetasol results in increased expression of LGALSL mRNA |
CTD |
PMID:27462272 |
|
NCBI chr14:94,996,991...95,004,499
Ensembl chr14:94,996,990...95,004,980
|
|
G |
Lin52 |
lin-52 DREAM MuvB core complex component |
increases expression |
ISO |
Clobetasol results in increased expression of LIN52 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 6:104,098,818...104,199,323
Ensembl chr 6:104,099,162...104,194,103
|
|
G |
Litaf |
lipopolysaccharide-induced TNF factor |
increases expression |
ISO |
Clobetasol results in increased expression of LITAF mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:4,656,308...4,692,981
Ensembl chr10:4,625,552...4,692,763
|
|
G |
Lman2 |
lectin, mannose-binding 2 |
increases expression |
ISO |
Clobetasol results in increased expression of LMAN2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr17:9,269,236...9,286,923
Ensembl chr17:9,269,022...9,287,265
|
|
G |
Lmcd1 |
LIM and cysteine-rich domains 1 |
increases expression |
ISO |
Clobetasol results in increased expression of LMCD1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:145,393,153...145,452,049
Ensembl chr 4:145,393,145...145,452,046
|
|
G |
Lpo |
lactoperoxidase |
increases expression |
ISO |
Clobetasol results in increased expression of LPO mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:72,606,950...72,626,220
Ensembl chr10:72,606,944...72,626,535
|
|
G |
Lrp1 |
LDL receptor related protein 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of LRP1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:63,380,325...63,461,029
Ensembl chr 7:63,380,356...63,460,910
|
|
G |
Lrp2 |
LDL receptor related protein 2 |
increases expression |
ISO |
Clobetasol results in increased expression of LRP2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:54,189,305...54,346,769
Ensembl chr 3:54,189,308...54,346,708
|
|
G |
Lrrc4b |
leucine rich repeat containing 4B |
decreases expression |
ISO |
Clobetasol results in decreased expression of LRRC4B mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:94,922,034...94,956,309
Ensembl chr 1:94,935,603...94,956,263
|
|
G |
Lrrtm2 |
leucine rich repeat transmembrane neuronal 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of LRRTM2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr18:26,817,816...26,822,864
Ensembl chr18:26,817,816...26,822,864
|
|
G |
Lsm4 |
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated |
increases expression |
ISO |
Clobetasol results in increased expression of LSM4 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr16:18,755,481...18,761,106
Ensembl chr16:18,755,484...18,760,926
|
|
G |
Lsm8 |
LSM8 homolog, U6 small nuclear RNA associated |
increases expression |
ISO |
Clobetasol results in increased expression of LSM8 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:47,306,259...47,312,125
Ensembl chr 4:47,306,295...47,314,293
|
|
G |
Ly75 |
lymphocyte antigen 75 |
decreases expression |
ISO |
Clobetasol results in decreased expression of LY75 protein |
CTD |
PMID:15086553 |
|
NCBI chr 3:44,764,702...44,852,219
Ensembl chr 3:44,765,122...44,852,374
|
|
G |
Macrod1 |
mono-ADP ribosylhydrolase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of MACROD1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:204,246,238...204,387,027
Ensembl chr 1:204,246,166...204,389,716
|
|
G |
Mafk |
MAF bZIP transcription factor K |
increases expression |
ISO |
Clobetasol results in increased expression of MAFK mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:14,834,628...14,856,414
Ensembl chr12:14,833,984...14,837,048 Ensembl chr12:14,833,984...14,837,048
|
|
G |
Magee1 |
MAGE family member E1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of MAGEE1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr X:70,189,242...70,192,789
Ensembl chr X:70,189,187...70,192,810
|
|
G |
Mageh1 |
MAGE family member H1 |
increases expression |
ISO |
Clobetasol results in increased expression of MAGEH1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr X:18,350,015...18,351,271
Ensembl chr X:18,349,774...18,351,516
|
|
G |
Manbal |
mannosidase beta like |
increases expression |
ISO |
Clobetasol results in increased expression of MANBAL mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:146,035,082...146,064,676
Ensembl chr 3:146,035,066...146,064,676
|
|
G |
Manf |
mesencephalic astrocyte-derived neurotrophic factor |
increases expression |
ISO |
Clobetasol results in increased expression of MANF mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:107,500,856...107,551,595
Ensembl chr 8:107,548,352...107,551,438
|
|
G |
Map1b |
microtubule-associated protein 1B |
decreases expression |
ISO |
Clobetasol results in decreased expression of MAP1B mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:30,817,261...30,910,458
Ensembl chr 2:30,817,261...30,910,317
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
increases expression |
ISO |
Clobetasol results in increased expression of MAP1LC3B mRNA |
CTD |
PMID:27462272 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
|
|
G |
Map2 |
microtubule-associated protein 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of MAP2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of MAP2K1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Mapk8ip2 |
mitogen-activated protein kinase 8 interacting protein 2 |
increases expression |
ISO |
Clobetasol results in increased expression of MAPK8IP2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:120,526,732...120,536,982
Ensembl chr 7:120,526,732...120,536,982
|
|
G |
Marf1 |
meiosis regulator and mRNA stability factor 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of MARF1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:888,053...932,760
Ensembl chr10:888,076...932,753
|
|
G |
Mast4 |
microtubule associated serine/threonine kinase family member 4 |
decreases expression |
ISO |
Clobetasol results in decreased expression of MAST4 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:33,893,241...34,483,682
Ensembl chr 2:33,894,436...34,483,723
|
|
G |
Mcm3ap |
minichromosome maintenance complex component 3 associated protein |
decreases expression |
ISO |
Clobetasol results in decreased expression of MCM3AP mRNA |
CTD |
PMID:27462272 |
|
NCBI chr20:12,127,570...12,165,165
Ensembl chr20:12,127,570...12,165,165
|
|
G |
Mdc1 |
mediator of DNA damage checkpoint 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of MDC1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr20:2,893,693...2,912,394
Ensembl chr20:2,895,505...2,910,240
|
|
G |
Mdh1 |
malate dehydrogenase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of MDH1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr14:95,630,625...95,645,920
Ensembl chr14:95,630,306...95,645,925
|
|
G |
Mdh2 |
malate dehydrogenase 2 |
increases expression |
ISO |
Clobetasol results in increased expression of MDH2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:20,894,269...20,907,225
Ensembl chr12:20,894,262...20,907,271
|
|
G |
Mdn1 |
midasin AAA ATPase 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of MDN1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:47,055,435...47,190,426
Ensembl chr 5:47,055,447...47,186,332
|
|
G |
Mecr |
mitochondrial trans-2-enoyl-CoA reductase |
increases expression |
ISO |
Clobetasol results in increased expression of MECR mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:144,029,684...144,056,373
Ensembl chr 5:144,029,731...144,055,863
|
|
G |
Megf9 |
multiple EGF-like-domains 9 |
increases expression |
ISO |
Clobetasol results in increased expression of MEGF9 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:83,993,565...84,105,622
Ensembl chr 5:83,993,565...84,105,622
|
|
G |
Mertk |
MER proto-oncogene, tyrosine kinase |
increases expression |
ISO |
Clobetasol results in increased expression of MERTK mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:115,939,351...116,045,141
Ensembl chr 3:115,939,351...116,046,554
|
|
G |
Mesd |
mesoderm development LRP chaperone |
increases expression |
ISO |
Clobetasol results in increased expression of MESD mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:137,866,707...137,879,999
Ensembl chr 1:137,874,242...137,879,999
|
|
G |
Metap1 |
methionyl aminopeptidase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of METAP1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:226,991,305...227,024,360
Ensembl chr 2:226,991,301...227,024,434
|
|
G |
Metrn |
meteorin, glial cell differentiation regulator |
increases expression |
ISO |
Clobetasol results in increased expression of METRN mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:14,816,684...14,818,702
Ensembl chr10:14,816,572...14,818,701
|
|
G |
Mex3a |
mex-3 RNA binding family member A |
decreases expression |
ISO |
Clobetasol results in decreased expression of MEX3A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:173,990,098...173,999,567
Ensembl chr 2:173,989,856...173,997,377
|
|
G |
Mfsd2a |
MFSD2 lysolipid transporter A, lysophospholipid |
increases expression |
ISO |
Clobetasol results in increased expression of MFSD2A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:135,225,801...135,240,744
Ensembl chr 5:135,225,816...135,240,690
|
|
G |
Mia3 |
MIA SH3 domain ER export factor 3 |
decreases expression |
ISO |
Clobetasol results in decreased expression of MIA3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr13:94,970,421...95,012,071
Ensembl chr13:94,970,424...95,011,972
|
|
G |
Mical3 |
microtubule associated monooxygenase, calponin and LIM domain containing 3 |
decreases expression |
ISO |
Clobetasol results in decreased expression of MICAL3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:154,152,776...154,353,274
Ensembl chr 4:154,153,834...154,302,590
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
decreases expression |
ISO |
Clobetasol results in decreased expression of MKI67 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mkrn3 |
makorin, ring finger protein, 3 |
increases expression |
ISO |
Clobetasol results in increased expression of MKRN3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:115,926,774...115,929,288
Ensembl chr 1:115,926,776...115,929,283
|
|
G |
Mlec |
malectin |
increases expression |
ISO |
Clobetasol results in increased expression of MLEC mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:41,458,234...41,468,710
Ensembl chr12:41,458,231...41,468,708
|
|
G |
Mllt1 |
MLLT1, super elongation complex subunit |
decreases expression |
ISO |
Clobetasol results in decreased expression of MLLT1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:1,731,077...1,775,985
Ensembl chr 9:1,731,080...1,775,970
|
|
G |
Mmadhc |
metabolism of cobalamin associated D |
increases expression |
ISO |
Clobetasol results in increased expression of MMADHC mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:34,708,649...34,726,554
Ensembl chr 3:34,708,649...34,726,771
|
|
G |
Mpc2 |
mitochondrial pyruvate carrier 2 |
increases expression |
ISO |
Clobetasol results in increased expression of MPC2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr13:77,728,176...77,747,664
Ensembl chr13:77,728,250...77,747,664
|
|
G |
Mrpl14 |
mitochondrial ribosomal protein L14 |
increases expression |
ISO |
Clobetasol results in increased expression of MRPL14 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:15,302,840...15,315,195
Ensembl chr 9:15,302,427...15,315,267
|
|
G |
Mrpl34 |
mitochondrial ribosomal protein L34 |
increases expression |
ISO |
Clobetasol results in increased expression of MRPL34 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr16:18,152,470...18,153,205
Ensembl chr16:18,151,342...18,153,208
|
|
G |
Mrpl46 |
mitochondrial ribosomal protein L46 |
increases expression |
ISO |
Clobetasol results in increased expression of MRPL46 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:132,698,872...132,707,639
Ensembl chr 1:132,698,601...132,707,628
|
|
G |
Mrps14 |
mitochondrial ribosomal protein S14 |
increases expression |
ISO |
Clobetasol results in increased expression of MRPS14 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr13:72,429,168...72,434,915
Ensembl chr13:72,408,558...72,434,915
|
|
G |
Mrps26 |
mitochondrial ribosomal protein S26 |
increases expression |
ISO |
Clobetasol results in increased expression of MRPS26 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:117,769,220...117,770,883
Ensembl chr 3:117,769,100...117,770,885
|
|
G |
Mrps27 |
mitochondrial ribosomal protein S27 |
increases expression |
ISO |
Clobetasol results in increased expression of MRPS27 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:30,740,007...30,808,577
Ensembl chr 2:30,740,033...30,808,577
|
|
G |
Msmo1 |
methylsterol monooxygenase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of MSMO1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016
|
|
G |
Msn |
moesin |
increases expression |
ISO |
Clobetasol results in increased expression of MSN mRNA |
CTD |
PMID:27462272 |
|
NCBI chr X:60,996,043...61,064,011
Ensembl chr X:60,995,951...61,065,628
|
|
G |
Mtcl2 |
microtubule crosslinking factor 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of MTCL2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:145,669,102...145,741,578
Ensembl chr 3:145,675,443...145,740,871
|
|
G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
increases expression |
ISO |
Clobetasol results in increased expression of MTHFD2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
decreases expression |
ISO |
Clobetasol results in decreased expression of MTOR mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Mvb12b |
multivesicular body subunit 12B |
decreases expression |
ISO |
Clobetasol results in decreased expression of MVB12B mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:17,034,002...17,192,658
Ensembl chr 3:17,034,003...17,193,202
|
|
G |
Mxd3 |
Max dimerization protein 3 |
increases expression |
ISO |
Clobetasol results in increased expression of MXD3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr17:9,301,430...9,305,156
Ensembl chr17:9,301,399...9,305,157
|
|
G |
Mycbp2 |
MYC binding protein 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of MYCBP2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr15:79,937,354...80,175,432
Ensembl chr15:79,937,354...80,175,498
|
|
G |
Myh9 |
myosin, heavy chain 9 |
decreases expression |
ISO |
Clobetasol results in decreased expression of MYH9 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:109,343,718...109,424,457
Ensembl chr 7:109,343,706...109,424,457
|
|
G |
Myo9a |
myosin IXA |
decreases expression |
ISO |
Clobetasol results in decreased expression of MYO9A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:60,149,234...60,352,330
Ensembl chr 8:60,149,234...60,350,514
|
|
G |
Nabp2 |
nucleic acid binding protein 2 |
increases expression |
ISO |
Clobetasol results in increased expression of NABP2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:830,949...836,551
Ensembl chr 7:830,949...838,027
|
|
G |
Nav3 |
neuron navigator 3 |
decreases expression |
ISO |
Clobetasol results in decreased expression of NAV3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:45,052,206...45,840,471
Ensembl chr 7:45,054,296...45,840,698
|
|
G |
Ncam2 |
neural cell adhesion molecule 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of NCAM2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr11:20,104,974...20,592,168
Ensembl chr11:20,104,925...20,591,984
|
|
G |
Nckap5l |
NCK-associated protein 5-like |
decreases expression |
ISO |
Clobetasol results in decreased expression of NCKAP5L mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:130,553,683...130,591,886
Ensembl chr 7:130,555,368...130,591,857
|
|
G |
Ncl |
nucleolin |
decreases expression |
ISO |
Clobetasol results in decreased expression of NCL mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:86,999,588...87,008,112
Ensembl chr 9:86,998,019...87,008,136
|
|
G |
Ncln |
nicalin |
increases expression |
ISO |
Clobetasol results in increased expression of NCLN mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:8,211,978...8,221,938
Ensembl chr 7:8,211,996...8,221,934
|
|
G |
Ndc1 |
NDC1 transmembrane nucleoporin |
increases expression |
ISO |
Clobetasol results in increased expression of NDC1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:122,155,992...122,202,295
Ensembl chr 5:122,155,967...122,202,291
|
|
G |
Ndfip1 |
Nedd4 family interacting protein 1 |
increases expression |
ISO |
Clobetasol results in increased expression of NDFIP1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr18:30,265,808...30,316,068
Ensembl chr18:30,250,613...30,322,311
|
|
G |
Ndufa2 |
NADH:ubiquinone oxidoreductase subunit A2 |
increases expression |
ISO |
Clobetasol results in increased expression of NDUFA2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr18:28,355,774...28,357,863
Ensembl chr18:28,355,774...28,358,076
|
|
G |
Ndufa8 |
NADH:ubiquinone oxidoreductase subunit A8 |
increases expression |
ISO |
Clobetasol results in increased expression of NDUFA8 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:19,386,062...19,402,090
Ensembl chr 3:19,386,065...19,402,071
|
|
G |
Ndufa9 |
NADH:ubiquinone oxidoreductase subunit A9 |
increases expression |
ISO |
Clobetasol results in increased expression of NDUFA9 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:159,659,242...159,688,034
Ensembl chr 4:159,659,242...159,688,018
|
|
G |
Ndufb10 |
NADH:ubiquinone oxidoreductase subunit B10 |
increases expression |
ISO |
Clobetasol results in increased expression of NDUFB10 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:13,749,273...13,751,434
Ensembl chr10:13,749,275...13,751,442
|
|
G |
Ndufb3 |
NADH:ubiquinone oxidoreductase subunit B3 |
increases expression |
ISO |
Clobetasol results in increased expression of NDUFB3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:60,129,240...60,139,452
Ensembl chr 9:60,129,154...60,139,446
|
|
G |
Ndufb5 |
NADH:ubiquinone oxidoreductase subunit B5 |
increases expression |
ISO |
Clobetasol results in increased expression of NDUFB5 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:115,519,248...115,533,589
Ensembl chr 2:115,519,154...115,533,589
|
|
G |
Ndufb6 |
NADH:ubiquinone oxidoreductase subunit B6 |
increases expression |
ISO |
Clobetasol results in increased expression of NDUFB6 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:55,400,543...55,410,110
Ensembl chr 5:55,400,543...55,410,181
|
|
G |
Ndufc1 |
NADH:ubiquinone oxidoreductase subunit C1 |
increases expression |
ISO |
Clobetasol results in increased expression of NDUFC1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:135,447,067...135,450,950
Ensembl chr 2:135,447,119...135,450,874
|
|
G |
Ndufc2 |
NADH:ubiquinone oxidoreductase subunit C2 |
increases expression |
ISO |
Clobetasol results in increased expression of NDUFC2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:151,711,965...151,718,188
Ensembl chr 1:151,711,901...151,718,189
|
|
G |
Ndufs7 |
NADH:ubiquinone oxidoreductase core subunit S7 |
increases expression |
ISO |
Clobetasol results in increased expression of NDUFS7 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:9,452,556...9,460,135
Ensembl chr 7:9,450,392...9,460,195
|
|
G |
Ndufv1 |
NADH:ubiquinone oxidoreductase core subunit V1 |
increases expression |
ISO |
Clobetasol results in increased expression of NDUFV1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:201,300,365...201,305,461
Ensembl chr 1:201,299,985...201,305,466
|
|
G |
Nell2 |
neural EGFL like 2 |
increases expression |
ISO |
Clobetasol results in increased expression of NELL2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:126,343,089...126,662,903
Ensembl chr 7:126,198,851...126,733,503
|
|
G |
Neu1 |
neuraminidase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of NEU1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr20:3,897,480...3,901,745
Ensembl chr20:3,897,480...3,901,745
|
|
G |
Nfasc |
neurofascin |
decreases expression |
ISO |
Clobetasol results in decreased expression of NFASC mRNA |
CTD |
PMID:27462272 |
|
NCBI chr13:43,997,223...44,183,863
Ensembl chr13:43,997,224...44,183,880
|
|
G |
Ngdn |
neuroguidin |
increases expression |
ISO |
Clobetasol results in increased expression of NGDN mRNA |
CTD |
PMID:27462272 |
|
NCBI chr15:28,489,950...28,497,286
Ensembl chr15:28,490,040...28,519,654
|
|
G |
Nhp2 |
NHP2 ribonucleoprotein |
increases expression |
ISO |
Clobetasol results in increased expression of NHP2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:35,877,057...35,880,399
Ensembl chr10:35,877,054...35,882,545
|
|
G |
Ninj1 |
ninjurin 1 |
increases expression |
ISO |
Clobetasol results in increased expression of NINJ1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr17:15,452,804...15,461,684
Ensembl chr17:15,452,813...15,461,704
|
|
G |
Ninl |
ninein-like |
decreases expression |
ISO |
Clobetasol results in decreased expression of NINL mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:139,748,353...139,814,683
Ensembl chr 3:139,748,355...139,814,622
|
|
G |
Nle1 |
notchless homolog 1 |
increases expression |
ISO |
Clobetasol results in increased expression of NLE1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:67,834,059...67,844,771
Ensembl chr10:67,834,062...67,842,658
|
|
G |
Nlgn2 |
neuroligin 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of NLGN2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:54,544,461...54,557,854
Ensembl chr10:54,544,588...54,558,434
|
|
G |
Nme1 |
NME/NM23 nucleoside diphosphate kinase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of NME1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:78,907,036...78,929,659
Ensembl chr10:78,906,083...78,916,408
|
|
G |
Nme4 |
NME/NM23 nucleoside diphosphate kinase 4 |
increases expression |
ISO |
Clobetasol results in increased expression of NME4 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:15,114,624...15,118,479
Ensembl chr10:15,002,926...15,118,479
|
|
G |
Nop10 |
NOP10 ribonucleoprotein |
increases expression |
ISO |
Clobetasol results in increased expression of NOP10 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:99,066,857...99,067,942
Ensembl chr 3:99,066,857...99,067,942
|
|
G |
Nopchap1 |
NOP protein chaperone 1 |
increases expression |
ISO |
Clobetasol results in increased expression of NOPCHAP1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:20,353,626...20,359,685
Ensembl chr 7:20,353,634...20,359,690
|
|
G |
Notch1 |
notch receptor 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of NOTCH1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Notch2 |
notch receptor 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of NOTCH2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:185,610,594...185,744,088
Ensembl chr 2:185,610,589...185,744,088
|
|
G |
Nova1 |
NOVA alternative splicing regulator 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of NOVA1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 6:63,780,105...63,905,567
Ensembl chr 6:63,783,489...63,906,289
|
|
G |
Npc1 |
NPC intracellular cholesterol transporter 1 |
increases expression |
ISO |
Clobetasol results in increased expression of NPC1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr18:3,379,482...3,425,100
Ensembl chr18:3,379,482...3,425,049
|
|
G |
Npc2 |
NPC intracellular cholesterol transporter 2 |
increases expression |
ISO |
Clobetasol results in increased expression of NPC2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 6:104,397,239...104,418,161
Ensembl chr 6:104,378,644...104,418,155
|
|
G |
Npm3 |
nucleophosmin/nucleoplasmin, 3 |
increases expression |
ISO |
Clobetasol results in increased expression of NPM3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:244,595,638...244,597,623
Ensembl chr 1:244,595,644...244,597,591
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of NQO1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of NR1D2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr15:7,524,257...7,550,553
Ensembl chr15:7,524,257...7,550,553
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity multiple interactions |
ISO |
Clobetasol results in increased activity of NR1I2 protein [Clobetasol results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA |
CTD |
PMID:25455453 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of NR2F1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:8,040,375...8,050,123
Ensembl chr 2:8,040,377...8,050,123
|
|
G |
Nsdhl |
NAD(P) dependent steroid dehydrogenase-like |
increases expression |
ISO |
Clobetasol results in increased expression of NSDHL mRNA |
CTD |
PMID:27462272 |
|
NCBI chr X:150,775,034...150,807,161
Ensembl chr X:150,775,080...150,807,142
|
|
G |
Nsg1 |
neuronal vesicle trafficking associated 1 |
increases expression |
ISO |
Clobetasol results in increased expression of NSG1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr14:72,648,771...72,670,521
Ensembl chr14:72,648,741...72,670,514
|
|
G |
Nsmce3 |
NSE3 homolog, SMC5-SMC6 complex component |
increases expression |
ISO |
Clobetasol results in increased expression of NSMCE3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:118,401,302...118,402,629
|
|
G |
Nt5dc2 |
5'-nucleotidase domain containing 2 |
increases expression |
ISO |
Clobetasol results in increased expression of NT5DC2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr16:6,322,485...6,330,538
Ensembl chr16:6,322,236...6,330,537
|
|
G |
Ntn1 |
netrin 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of NTN1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:52,899,933...53,098,591
Ensembl chr10:52,899,934...53,085,326
|
|
G |
Nubp2 |
NUBP iron-sulfur cluster assembly factor 2 |
increases expression |
ISO |
Clobetasol results in increased expression of NUBP2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:13,903,224...13,906,928
Ensembl chr10:13,903,224...13,906,969
|
|
G |
Nudt9 |
nudix hydrolase 9 |
increases expression |
ISO |
Clobetasol results in increased expression of NUDT9 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr14:5,675,376...5,693,332
Ensembl chr14:5,675,382...5,693,142
|
|
G |
Nxn |
nucleoredoxin |
increases expression |
ISO |
Clobetasol results in increased expression of NXN mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:61,109,322...61,247,578
Ensembl chr10:61,110,020...61,248,251
|
|
G |
Odc1 |
ornithine decarboxylase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of ODC1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
|
|
G |
Olfm2 |
olfactomedin 2 |
increases expression |
ISO |
Clobetasol results in increased expression of OLFM2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:19,204,472...19,282,154
Ensembl chr 8:19,204,475...19,282,117
|
|
G |
Olig1 |
oligodendrocyte transcription factor 1 |
increases expression |
ISO |
Clobetasol results in increased expression of OLIG1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr11:30,514,379...30,516,521
Ensembl chr11:30,514,379...30,516,521
|
|
G |
Onecut2 |
one cut homeobox 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of ONECUT2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr18:57,831,647...57,890,884
Ensembl chr18:57,832,111...57,879,629
|
|
G |
P4hb |
prolyl 4-hydroxylase subunit beta |
increases expression |
ISO |
Clobetasol results in increased expression of P4HB mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:105,836,972...105,848,583
Ensembl chr10:105,836,982...105,848,500
|
|
G |
P4htm |
prolyl 4-hydroxylase, transmembrane |
increases expression |
ISO |
Clobetasol results in increased expression of P4HTM mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:109,274,629...109,292,802
Ensembl chr 8:109,274,626...109,292,473
|
|
G |
Pabpc1 |
poly(A) binding protein, cytoplasmic 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of PABPC1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:67,777,438...67,789,731
Ensembl chr 7:67,777,381...67,789,744
|
|
G |
Parl |
presenilin associated, rhomboid-like |
increases expression |
ISO |
Clobetasol results in increased expression of PARL mRNA |
CTD |
PMID:27462272 |
|
NCBI chr11:80,594,059...80,620,506
Ensembl chr11:80,593,192...80,620,506
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of PARP1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pbxip1 |
PBX homeobox interacting protein 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of PBXIP1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:174,856,339...174,868,922
Ensembl chr 2:174,856,397...174,868,919
|
|
G |
Pcdh10 |
protocadherin 10 |
decreases expression |
ISO |
Clobetasol results in decreased expression of PCDH10 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:128,617,212...128,683,354
Ensembl chr 2:128,617,174...128,677,190
|
|
G |
Pcdh17 |
protocadherin 17 |
decreases expression |
ISO |
Clobetasol results in decreased expression of PCDH17 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr15:60,222,088...60,316,172
Ensembl chr15:60,222,004...60,313,999
|
|
G |
Pcdhga2 |
protocadherin gamma subfamily A, 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of PCDHGA2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr18:29,493,954...29,667,865
Ensembl chr18:29,493,954...29,667,868
|
|
G |
Pcdhgc3 |
protocadherin gamma subfamily C, 3 |
decreases expression |
ISO |
Clobetasol results in decreased expression of PCDHGC3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr18:29,633,016...29,667,865
Ensembl chr18:29,493,954...29,667,868
|
|
G |
Pcf11 |
PCF11 cleavage and polyadenylation factor subunit |
increases expression |
ISO |
Clobetasol results in increased expression of PCF11 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:146,694,045...146,724,030
Ensembl chr 1:146,697,646...146,724,124
|
|
G |
Pcolce |
procollagen C-endopeptidase enhancer |
increases expression |
ISO |
Clobetasol results in increased expression of PCOLCE mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:19,084,191...19,090,508
Ensembl chr12:19,084,210...19,090,508
|
|
G |
Pcyox1l |
prenylcysteine oxidase 1 like |
increases expression |
ISO |
Clobetasol results in increased expression of PCYOX1L mRNA |
CTD |
PMID:27462272 |
|
NCBI chr18:55,150,637...55,161,334
Ensembl chr18:55,150,650...55,161,327
|
|
G |
Pdcl3 |
phosducin-like 3 |
increases expression |
ISO |
Clobetasol results in increased expression of PDCL3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:41,234,322...41,243,769
Ensembl chr 9:41,234,234...41,243,735
|
|
G |
Pdia4 |
protein disulfide isomerase family A, member 4 |
increases expression |
ISO |
Clobetasol results in increased expression of PDIA4 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:76,803,198...76,822,107
|
|
G |
Pdia6 |
protein disulfide isomerase family A, member 6 |
increases expression |
ISO |
Clobetasol results in increased expression of PDIA6 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 6:40,062,980...40,080,223
Ensembl chr 6:40,062,926...40,080,613
|
|
G |
Peak1 |
pseudopodium-enriched atypical kinase 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of PEAK1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:56,605,040...56,819,748
Ensembl chr 8:56,609,015...56,819,096
|
|
G |
Pebp1 |
phosphatidylethanolamine binding protein 1 |
increases expression |
ISO |
Clobetasol results in increased expression of PEBP1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:39,302,864...39,307,064
Ensembl chr12:39,302,840...39,307,862
|
|
G |
Pfdn6 |
prefoldin subunit 6 |
increases expression |
ISO |
Clobetasol results in increased expression of PFDN6 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr20:4,945,959...4,947,433
Ensembl chr20:4,945,959...4,947,433
|
|
G |
Pfn1 |
profilin 1 |
increases expression |
ISO |
Clobetasol results in increased expression of PFN1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:55,365,263...55,367,968
Ensembl chr10:55,365,262...55,527,631
|
|
G |
Pgam1 |
phosphoglycerate mutase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of PGAM1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:240,723,832...240,731,443
Ensembl chr 1:240,723,920...240,738,452
|
|
G |
Pgd |
phosphogluconate dehydrogenase |
increases expression |
ISO |
Clobetasol results in increased expression of PGD mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
|
|
G |
Pgk1 |
phosphoglycerate kinase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of PGK1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
|
|
G |
Phb1 |
prohibitin 1 |
increases expression |
ISO |
Clobetasol results in increased expression of PHB1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042
|
|
G |
Phf3 |
PHD finger protein 3 |
decreases expression |
ISO |
Clobetasol results in decreased expression of PHF3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:33,063,855...33,136,013
Ensembl chr 9:33,063,857...33,135,994
|
|
G |
Phf5a |
PHD finger protein 5A |
increases expression |
ISO |
Clobetasol results in increased expression of PHF5A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:113,378,469...113,385,035
Ensembl chr 7:113,378,471...113,385,460
|
|
G |
Phgdh |
phosphoglycerate dehydrogenase |
increases expression |
ISO |
Clobetasol results in increased expression of PHGDH mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
|
|
G |
Phrf1 |
PHD and ring finger domains 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of PHRF1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:196,333,663...196,366,901
Ensembl chr 1:196,333,903...196,366,892
|
|
G |
Pigs |
phosphatidylinositol glycan anchor biosynthesis, class S |
increases expression |
ISO |
Clobetasol results in increased expression of PIGS mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:63,222,611...63,237,190
Ensembl chr10:63,222,572...63,237,187
|
|
G |
Pik3c2b |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta |
decreases expression |
ISO |
Clobetasol results in decreased expression of PIK3C2B mRNA |
CTD |
PMID:27462272 |
|
NCBI chr13:44,494,673...44,555,663
Ensembl chr13:44,495,050...44,555,612
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
increases expression |
ISO |
Clobetasol results in increased expression of PIK3R1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
|
|
G |
Pim3 |
Pim-3 proto-oncogene, serine/threonine kinase |
increases expression |
ISO |
Clobetasol results in increased expression of PIM3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:119,953,377...119,956,587
Ensembl chr 7:119,953,175...119,956,587
|
|
G |
Pip4k2a |
phosphatidylinositol-5-phosphate 4-kinase type 2 alpha |
increases expression |
ISO |
Clobetasol results in increased expression of PIP4K2A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr17:81,496,669...81,668,180
Ensembl chr17:81,496,670...81,668,029
|
|
G |
Pip4p2 |
phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2 |
increases expression |
ISO |
Clobetasol results in increased expression of PIP4P2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:28,259,821...28,307,225
Ensembl chr 5:28,259,760...28,307,225
|
|
G |
Pkm |
pyruvate kinase M1/2 |
increases expression |
ISO |
Clobetasol results in increased expression of PKM mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
|
|
G |
Plcg2 |
phospholipase C, gamma 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of PLCG2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr19:45,547,416...45,683,930
Ensembl chr19:45,547,416...45,683,930
|
|
G |
Plk2 |
polo-like kinase 2 |
increases expression |
ISO |
Clobetasol results in increased expression of PLK2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:41,969,176...41,974,945
Ensembl chr 2:41,969,176...41,974,947
|
|
G |
Plod1 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of PLOD1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:158,340,674...158,367,581
Ensembl chr 5:158,340,490...158,367,620
|
|
G |
Plod3 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 |
increases expression |
ISO |
Clobetasol results in increased expression of PLOD3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:19,676,384...19,686,945
Ensembl chr12:19,676,386...19,686,960
|
|
G |
Pltp |
phospholipid transfer protein |
increases expression |
ISO |
Clobetasol results in increased expression of PLTP mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:153,574,825...153,592,647
Ensembl chr 3:153,574,825...153,592,647
|
|
G |
Plxna1 |
plexin A1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of PLXNA1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:121,737,934...121,782,901
Ensembl chr 4:121,737,945...122,024,196
|
|
G |
Plxna2 |
plexin A2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of PLXNA2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr13:106,163,103...106,358,979
Ensembl chr13:106,163,103...106,358,979
|
|
G |
Plxna4 |
plexin A4 |
decreases expression |
ISO |
Clobetasol results in decreased expression of PLXNA4 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:60,720,246...61,162,206
Ensembl chr 4:60,720,255...61,162,206
|
|
G |
Plxnc1 |
plexin C1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of PLXNC1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:29,390,038...29,543,985
Ensembl chr 7:29,390,048...29,543,779
|
|
G |
Plxnd1 |
plexin D1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of PLXND1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:149,002,786...149,043,097
Ensembl chr 4:149,002,784...149,043,244
|
|
G |
Polr1c |
RNA polymerase I and III subunit C |
increases expression |
ISO |
Clobetasol results in increased expression of POLR1C mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:14,735,740...14,739,852
Ensembl chr 9:14,735,714...14,739,852
|
|
G |
Polr1d |
RNA polymerase I and III subunit D |
increases expression |
ISO |
Clobetasol results in increased expression of POLR1D mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:7,970,592...8,004,157
Ensembl chr12:7,970,595...8,005,624
|
|
G |
Polr2a |
RNA polymerase II subunit A |
decreases expression |
ISO |
Clobetasol results in decreased expression of POLR2A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:54,452,438...54,478,486
Ensembl chr10:54,452,441...54,478,455
|
|
G |
Polr2i |
RNA polymerase II subunit I |
increases expression |
ISO |
Clobetasol results in increased expression of POLR2I mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:85,483,515...85,484,952
Ensembl chr 1:85,483,515...85,484,952
|
|
G |
Polr2l |
RNA polymerase II, I and III subunit L |
increases expression |
ISO |
Clobetasol results in increased expression of POLR2L mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:196,570,051...196,572,060
Ensembl chr19:8,335,702...8,335,905
|
|
G |
Polr3h |
RNA polymerase III subunit H |
increases expression |
ISO |
Clobetasol results in increased expression of POLR3H mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 7:113,429,434...113,439,743
Ensembl chr 7:113,429,451...113,439,778
|
|
G |
Polr3k |
RNA polymerase III subunit K |
increases expression |
ISO |
Clobetasol results in increased expression of POLR3K mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:168,982,846...168,987,043
Ensembl chr 3:168,982,812...168,987,040
|
|
G |
Ppie |
peptidylprolyl isomerase E |
increases expression |
ISO |
Clobetasol results in increased expression of PPIE mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:135,406,172...135,419,332
Ensembl chr 5:135,406,176...135,419,235
|
|
G |
Ppil1 |
peptidylprolyl isomerase like 1 |
increases expression |
ISO |
Clobetasol results in increased expression of PPIL1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr20:7,302,292...7,322,349
Ensembl chr20:7,302,621...7,322,354
|
|
G |
Ppm1k |
protein phosphatase, Mg2+/Mn2+ dependent, 1K |
increases expression |
ISO |
Clobetasol results in increased expression of PPM1K mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:87,612,198...87,638,993
Ensembl chr 4:87,612,204...87,636,152
|
|
G |
Ppme1 |
protein phosphatase methylesterase 1 |
increases expression |
ISO |
Clobetasol results in increased expression of PPME1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:154,668,099...154,715,079
Ensembl chr 1:154,668,109...154,715,110
|
|
G |
Ppp1ca |
protein phosphatase 1 catalytic subunit alpha |
increases expression |
ISO |
Clobetasol results in increased expression of PPP1CA mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:201,485,117...201,488,734
Ensembl chr 1:201,485,085...201,497,327
|
|
G |
Ppp1cb |
protein phosphatase 1 catalytic subunit beta |
increases expression |
ISO |
Clobetasol results in increased expression of PPP1CB mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 6:23,958,813...23,992,841
Ensembl chr 6:23,960,998...23,992,824
|
|
G |
Ppp1r14b |
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
increases expression |
ISO |
Clobetasol results in increased expression of PPP1R14B mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:204,165,210...204,167,320
Ensembl chr 1:204,163,299...204,167,319 Ensembl chr12:204,163,299...204,167,319
|
|
G |
Ppp1r26 |
protein phosphatase 1, regulatory subunit 26 |
decreases expression |
ISO |
Clobetasol results in decreased expression of PPP1R26 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:11,781,504...11,790,076
Ensembl chr 3:11,781,295...11,790,073
|
|
G |
Ppp1r35 |
protein phosphatase 1, regulatory subunit 35 |
increases expression |
ISO |
Clobetasol results in increased expression of PPP1R35 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:18,915,909...18,919,253
|
|
G |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
increases expression |
ISO |
Clobetasol results in increased expression of PPP1R3C mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:234,460,958...234,465,961
Ensembl chr 1:234,460,652...234,465,961
|
|
G |
Ppp2r1a |
protein phosphatase 2 scaffold subunit A alpha |
increases expression |
ISO |
Clobetasol results in increased expression of PPP2R1A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:60,540,223...60,559,467
Ensembl chr 1:60,540,194...60,560,129
|
|
G |
Ppp4c |
protein phosphatase 4, catalytic subunit |
increases expression |
ISO |
Clobetasol results in increased expression of PPP4C mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:181,392,899...181,399,703
Ensembl chr 1:181,392,923...181,399,659
|
|
G |
Ppp5c |
protein phosphatase 5, catalytic subunit |
increases expression |
ISO |
Clobetasol results in increased expression of PPP5C mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:77,690,203...77,714,507
Ensembl chr 1:77,690,208...77,714,456
|
|
G |
Prag1 |
PEAK1 related kinase activating pseudokinase 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of PRAG1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr16:56,087,885...56,141,153
Ensembl chr16:56,087,885...56,141,153
|
|
G |
Prdx1 |
peroxiredoxin 1 |
increases expression |
ISO |
Clobetasol results in increased expression of PRDX1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
|
|
G |
Prdx2 |
peroxiredoxin 2 |
increases expression |
ISO |
Clobetasol results in increased expression of PRDX2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
|
|
G |
Prdx3 |
peroxiredoxin 3 |
increases expression |
ISO |
Clobetasol results in increased expression of PRDX3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:260,001,642...260,014,064
Ensembl chr 1:260,001,637...260,014,111
|
|
G |
Prdx5 |
peroxiredoxin 5 |
increases expression |
ISO |
Clobetasol results in increased expression of PRDX5 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:204,099,826...204,103,589
Ensembl chr 1:204,099,826...204,114,268
|
|
G |
Prkca |
protein kinase C, alpha |
decreases expression |
ISO |
Clobetasol results in decreased expression of PRKCA mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
|
|
G |
Prkcb |
protein kinase C, beta |
decreases expression |
ISO |
Clobetasol results in decreased expression of PRKCB mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
|
|
G |
Prob1 |
proline-rich basic protein 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of PROB1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr18:27,242,511...27,247,355
Ensembl chr18:27,244,280...27,247,333
|
|
G |
Prps2 |
phosphoribosyl pyrophosphate synthetase 2 |
increases expression |
ISO |
Clobetasol results in increased expression of PRPS2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr X:26,975,915...27,013,184
Ensembl chr X:26,976,061...27,013,181
|
|
G |
Prr12 |
proline rich 12 |
decreases expression |
ISO |
Clobetasol results in decreased expression of PRR12 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:95,510,015...95,534,002
Ensembl chr 1:95,509,931...95,533,652
|
|
G |
Prrc2b |
proline-rich coiled-coil 2B |
decreases expression |
ISO |
Clobetasol results in decreased expression of PRRC2B mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:15,433,357...15,519,105
Ensembl chr 3:15,465,294...15,519,104
|
|
G |
Prrc2c |
proline-rich coiled-coil 2C |
decreases expression |
ISO |
Clobetasol results in decreased expression of PRRC2C mRNA |
CTD |
PMID:27462272 |
|
NCBI chr13:75,003,995...75,073,701
Ensembl chr13:75,004,010...75,073,643
|
|
G |
Prune2 |
prune homolog 2 with BCH domain |
increases expression |
ISO |
Clobetasol results in increased expression of PRUNE2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:214,352,586...214,624,848
Ensembl chr 1:214,352,955...214,622,650
|
|
G |
Psma2 |
proteasome 20S subunit alpha 2 |
increases expression |
ISO |
Clobetasol results in increased expression of PSMA2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr17:50,554,536...50,564,923
Ensembl chr17:50,551,924...50,564,938
|
|
G |
Psma5 |
proteasome 20S subunit alpha 5 |
increases expression |
ISO |
Clobetasol results in increased expression of PSMA5 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:195,896,369...195,919,733
Ensembl chr 2:195,896,365...195,919,731
|
|
G |
Psma6 |
proteasome 20S subunit alpha 6 |
increases expression |
ISO |
Clobetasol results in increased expression of PSMA6 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 6:72,765,534...72,796,554
Ensembl chr 6:72,765,473...72,796,554
|
|
G |
Psmb3 |
proteasome 20S subunit beta 3 |
increases expression |
ISO |
Clobetasol results in increased expression of PSMB3 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:82,697,425...82,704,521
Ensembl chr10:82,697,425...82,704,521
|
|
G |
Psmb4 |
proteasome 20S subunit beta 4 |
increases expression |
ISO |
Clobetasol results in increased expression of PSMB4 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:182,442,757...182,445,532
Ensembl chr 2:182,442,756...182,445,746
|
|
G |
Psmb5 |
proteasome 20S subunit beta 5 |
increases expression |
ISO |
Clobetasol results in increased expression of PSMB5 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr15:28,072,772...28,077,367
Ensembl chr15:28,072,781...28,077,440
|
|
G |
Psmb7 |
proteasome 20S subunit beta 7 |
increases expression |
ISO |
Clobetasol results in increased expression of PSMB7 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:22,357,777...22,417,748
Ensembl chr 3:22,354,698...22,417,937
|
|
G |
Psmc5 |
proteasome 26S subunit, ATPase 5 |
increases expression |
ISO |
Clobetasol results in increased expression of PSMC5 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:91,187,763...91,193,697
Ensembl chr10:91,187,743...91,213,135
|
|
G |
Psmd13 |
proteasome 26S subunit, non-ATPase 13 |
increases expression |
ISO |
Clobetasol results in increased expression of PSMD13 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:195,964,617...195,976,895
Ensembl chr 1:195,964,138...195,976,905
|
|
G |
Psmd6 |
proteasome 26S subunit, non-ATPase 6 |
increases expression |
ISO |
Clobetasol results in increased expression of PSMD6 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr15:11,102,174...11,112,180
Ensembl chr15:11,102,180...11,205,620
|
|
G |
Psph |
phosphoserine phosphatase |
increases expression |
ISO |
Clobetasol results in increased expression of PSPH mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:26,882,524...26,905,084
Ensembl chr12:26,883,133...26,905,074
|
|
G |
Ptbp2 |
polypyrimidine tract binding protein 2 |
decreases expression |
ISO |
Clobetasol results in decreased expression of PTBP2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:207,812,659...207,874,019
Ensembl chr 2:207,812,920...207,873,506
|
|
G |
Ptcd2 |
pentatricopeptide repeat domain 2 |
increases expression |
ISO |
Clobetasol results in increased expression of PTCD2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:30,712,276...30,739,968
Ensembl chr 2:30,712,280...30,739,942
|
|
G |
Ptdss2 |
phosphatidylserine synthase 2 |
increases expression |
ISO |
Clobetasol results in increased expression of PTDSS2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:196,241,439...196,267,632
Ensembl chr 1:196,241,494...196,267,685
|
|
G |
Ptges2 |
prostaglandin E synthase 2 |
increases expression |
ISO |
Clobetasol results in increased expression of PTGES2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:15,690,501...15,697,688
Ensembl chr 3:15,690,501...15,697,688
|
|
G |
Ptgfrn |
prostaglandin F2 receptor inhibitor |
increases expression |
ISO |
Clobetasol results in increased expression of PTGFRN mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 2:188,469,521...188,544,795
Ensembl chr 2:188,469,521...188,544,795
|
|
G |
Ptpa |
protein phosphatase 2 phosphatase activator |
increases expression |
ISO |
Clobetasol results in increased expression of PTPA mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:13,689,742...13,720,287
Ensembl chr 3:13,689,741...13,722,549
|
|
G |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
decreases expression |
ISO |
Clobetasol results in decreased expression of PTPRF mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:131,741,959...131,824,000
Ensembl chr 5:131,742,754...131,810,023
|
|
G |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
decreases expression |
ISO |
Clobetasol results in decreased expression of PTPRS mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:1,245,408...1,307,015
Ensembl chr 9:1,245,410...1,306,947
|
|
G |
Pttg1ip |
PTTG1 interacting protein |
increases expression |
ISO |
Clobetasol results in increased expression of PTTG1IP mRNA |
CTD |
PMID:27462272 |
|
NCBI chr20:11,030,013...11,047,742
Ensembl chr20:11,030,015...11,047,316
|
|
G |
Pxmp2 |
peroxisomal membrane protein 2 |
increases expression |
ISO |
Clobetasol results in increased expression of PXMP2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr12:46,394,051...46,404,561
Ensembl chr12:46,394,193...46,404,557
|
|
G |
Pycr2 |
pyrroline-5-carboxylate reductase 2 |
increases expression |
ISO |
Clobetasol results in increased expression of PYCR2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr13:92,626,462...92,630,256
Ensembl chr13:92,626,471...92,634,184
|
|
G |
Qdpr |
quinoid dihydropteridine reductase |
increases expression |
ISO |
Clobetasol results in increased expression of QDPR mRNA |
CTD |
PMID:27462272 |
|
NCBI chr14:65,670,251...65,683,853
Ensembl chr14:65,670,131...65,683,854
|
|
G |
Qser1 |
glutamine and serine rich 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of QSER1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:91,137,516...91,202,426
Ensembl chr 3:91,140,967...91,202,052
|
|
G |
R3hdm1 |
R3H domain containing 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of R3HDM1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr13:39,595,848...39,733,876
Ensembl chr13:39,595,848...39,733,876
|
|
G |
Rab1a |
RAB1A, member RAS oncogene family |
increases expression |
ISO |
Clobetasol results in increased expression of RAB1A mRNA |
CTD |
PMID:27462272 |
|
NCBI chr14:94,422,219...94,448,799
Ensembl chr14:94,415,275...94,448,248
|
|
G |
Rabl6 |
RAB, member RAS oncogene family-like 6 |
decreases expression |
ISO |
Clobetasol results in decreased expression of RABL6 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 3:8,402,666...8,428,588
Ensembl chr 3:8,402,672...8,428,611
|
|
G |
Raph1 |
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 |
decreases expression |
ISO |
Clobetasol results in decreased expression of RAPH1 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 9:61,907,476...61,990,170
Ensembl chr 9:61,907,758...61,961,209
|
|
G |
Raver2 |
ribonucleoprotein, PTB-binding 2 |
increases expression |
ISO |
Clobetasol results in increased expression of RAVER2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:115,700,985...115,780,465
Ensembl chr 5:115,701,326...115,778,792
|
|
G |
Rbbp4 |
RB binding protein 4, chromatin remodeling factor |
increases expression |
ISO |
Clobetasol results in increased expression of RBBP4 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:141,655,863...141,675,157
Ensembl chr 5:141,638,421...141,675,284 Ensembl chr 2:141,638,421...141,675,284
|
|
G |
Rbbp6 |
RB binding protein 6, ubiquitin ligase |
decreases expression |
ISO |
Clobetasol results in decreased expression of RBBP6 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 1:177,503,988...177,537,397
Ensembl chr 1:177,503,313...177,535,678
|
|
G |
Rbm15b |
RNA binding motif protein 15B |
decreases expression |
ISO |
Clobetasol results in decreased expression of RBM15B mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:107,543,613...107,546,678
Ensembl chr 8:107,525,898...107,551,696
|
|
G |
Rcc2 |
regulator of chromosome condensation 2 |
increases expression |
ISO |
Clobetasol results in increased expression of RCC2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:152,994,406...153,017,223
Ensembl chr 5:152,993,665...153,017,205
|
|
G |
Reep5 |
receptor accessory protein 5 |
increases expression |
ISO |
Clobetasol results in increased expression of REEP5 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr18:25,945,375...25,983,271
Ensembl chr18:25,945,381...25,976,509
|
|
G |
Rere |
arginine-glutamic acid dipeptide repeats |
decreases expression |
ISO |
Clobetasol results in decreased expression of RERE mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 5:160,765,855...161,097,678
Ensembl chr 5:160,765,934...161,097,677
|
|
G |
Rev3l |
REV3 like, DNA directed polymerase zeta catalytic subunit |
decreases expression |
ISO |
Clobetasol results in decreased expression of REV3L mRNA |
CTD |
PMID:27462272 |
|
NCBI chr20:43,131,841...43,290,102
Ensembl chr20:43,132,363...43,290,099
|
|
G |
Rex1bd |
required for excision 1-B domain containing |
increases expression |
ISO |
Clobetasol results in increased expression of REX1BD mRNA |
CTD |
PMID:27462272 |
|
NCBI chr16:18,922,050...18,924,521
Ensembl chr16:18,922,037...18,924,526
|
|
G |
Rflnb |
refilin B |
increases expression |
ISO |
Clobetasol results in increased expression of RFLNB mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:60,893,693...60,899,970
Ensembl chr10:60,893,713...60,899,976
|
|
G |
Rfx7 |
regulatory factor X, 7 |
decreases expression |
ISO |
Clobetasol results in decreased expression of RFX7 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 8:73,254,051...73,339,209
Ensembl chr 8:73,254,051...73,339,209
|
|
G |
Rheb |
Ras homolog, mTORC1 binding |
increases expression |
ISO |
Clobetasol results in increased expression of RHEB mRNA |
CTD |
PMID:27462272 |
|
NCBI chr 4:10,278,970...10,320,160
Ensembl chr 4:10,279,370...10,320,160
|
|
G |
Rhot2 |
ras homolog family member T2 |
increases expression |
ISO |
Clobetasol results in increased expression of RHOT2 mRNA |
CTD |
PMID:27462272 |
|
NCBI chr10:14,858,954...14,864,751
Ensembl chr10:14,858,956...14,864,751
|
|
| |